Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Full Poster Schedule
Home
Full Poster Schedule
All Days
Sun, Dec 3
Mon, Dec 4
Tue, Dec 5
Wed, Dec 6
Full Poster Schedule
Type here to filter the list
Monday, December 4, 2023
10:45 AM – 11:45 AM
Student Posters
10:45 AM – 11:45 AM
(2-001) Safety and Efficacy of Hydrocortisone Discontinuation Strategies in Septic Shock
Favorite
10:45 AM – 11:45 AM
(2-002) Review of Immunization Documentation Disparities among non-English speaking Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(2-003) Efficacy and Safety of Inhaled Milrinone Versus Inhaled Epoprostenol in Critically Ill Adults
Favorite
10:45 AM – 11:45 AM
(2-004) Evaluation of the Treatment of Uncomplicated Gram-negative Bacteremia within a Community Teaching Health-System
Favorite
10:45 AM – 11:45 AM
(2-005) Appropriate Treatment of Blood Pressure in Psychiatric Patients
Favorite
10:45 AM – 11:45 AM
(2-006) Development of a pharmacist-led transitions of care process for patients newly diagnosed with HIV-1 Infection during hospitalization in the Deep South
Favorite
10:45 AM – 11:45 AM
(2-007) Cross-Sectional Survey of Alabama Community Pharmacists’ Knowledge and Self-Efficacy Regarding Recommending and Stocking Fentanyl Test Strips (FTS)
Favorite
10:45 AM – 11:45 AM
(2-008) Community Pharmacists’ General Attitudes and Beliefs Surrounding Recommending and Stocking Fentanyl Test Strips (FTS): A Cross-Sectional Survey in Alabama
Favorite
10:45 AM – 11:45 AM
(2-009) Student Performance in Writing SOAP Notes Throughout the Didactic Pharmacy Curriculum
Favorite
10:45 AM – 11:45 AM
(2-010) Evaluation of Hormonal Contraception Patient Counseling Instruction in a Pharmacy School Curriculum
Favorite
10:45 AM – 11:45 AM
(2-011) Impact of Pharmacist Intervention and Health-System Affiliated Outpatient Pharmacy Filling on Patients’ Diabetes Control at an Outpatient Ambulatory Care Clinic
Favorite
10:45 AM – 11:45 AM
(2-012) Evaluation of Serum Procalcitonin Utilization for Antibiotic Therapy Adjustments in Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(2-013) Prevalence of Potentially Inappropriate Medications in Older Adults and the 2023 American Geriatrics Society Beers Criteria in an Outpatient Family Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(2-014) Impact of a Pharmacist-led Telehealth Service for Patients with Uncontrolled Type 2 Diabetes in a Rural Alabama Veterans Affairs Clinic
Favorite
10:45 AM – 11:45 AM
(2-015) Integrating Community Pharmacists into Care Teams for Homebound Older Adults Living with Dementia: Perspectives of Home Health Providers
Favorite
10:45 AM – 11:45 AM
(2-016) Impact of Employment and Overall Academic Performance on Success and Satisfaction in Pharmacy Residency Outcomes
Favorite
10:45 AM – 11:45 AM
(2-017) Prevalence of anxiety and/or depression among Auburn University pharmacy students
Favorite
10:45 AM – 11:45 AM
(2-018) Impact of an Escape Box Activity in an Introductory Pharmacy Unit
Favorite
10:45 AM – 11:45 AM
(2-019) Use of Albumin in Patients with Cirrhosis Experiencing Acute Kidney Injury
Favorite
10:45 AM – 11:45 AM
(2-020) Evaluation of barriers to engagement among persons with poor retention in care following HIV diagnosis during hospitalization
Favorite
10:45 AM – 11:45 AM
(2-021) Association Between Hyperglycemia and Epilepsy: From Clinical Implication to Therapeutics
Favorite
10:45 AM – 11:45 AM
(2-022) The Diabetes Prevention Program to Treat Overweight and Obesity (DPP-TOO)- Results of an 18-week pilot
Favorite
10:45 AM – 11:45 AM
(2-023) Using Estimated Glomerular Filtration Rate (eGFR) versus Creatinine Clearance (CrCl) in Antibiotic Treatment – A Comparative Analysis of Package Inserts
Favorite
10:45 AM – 11:45 AM
(2-024) Patient-Specific Factors Associated with Adherence to Post-Acute Kidney Injury Follow-Up After Hospitalization
Favorite
10:45 AM – 11:45 AM
(2-025) Clinical and Financial Outcomes of a Pharmacist-Led Continuous Glucose Monitoring Clinic in a Federally Qualified Health Center
Favorite
10:45 AM – 11:45 AM
(2-026) Targeting Neprilysin as a Modifier of Physical Function in a Pre-Clinical Model of Alzheimer’s Disease
Favorite
10:45 AM – 11:45 AM
(2-027) Knowledge and Confidence of Pediatric Pharmacists Related to Direct Oral Anticoagulants
Favorite
10:45 AM – 11:45 AM
(2-028) Getting fungi with micafungin: Assessment of the effectiveness of micafungin prophylaxis in high-risk pediatric patients.
Favorite
10:45 AM – 11:45 AM
(2-030) Empiric Antibiotic Selection for Sepsis: Retrospective Review of an Institutional Guide and Impact on Patient Outcomes at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-031) Antibiotic Sequence of Administration in Nosocomial Pneumonias: Does Order HAPpen to Matter?
Favorite
10:45 AM – 11:45 AM
(2-032) Evaluating the Appropriateness of Cosyntropin Dosing for Adrenocorticotropic Hormone Stimulation Tests in Neonates and Infants
Favorite
10:45 AM – 11:45 AM
(2-033) Comparison of Curricular Design in a Diabetes Therapeutics Module
Favorite
10:45 AM – 11:45 AM
(2-034) Evaluation of Mental Health Screens in Pediatric Patients with Cystic Fibrosis taking elexacaftor/tezacaftor/ivacaftor.
Favorite
10:45 AM – 11:45 AM
(2-035) Association Between Lithium in Drinking Water and Mortality Due to Alzheimer's Disease in Alabama
Favorite
10:45 AM – 11:45 AM
(2-036) Association between Medication Regimen Complexity Index (MRCI) Scores and Diagnosis on a Pediatric Hospital Medicine Service
Favorite
10:45 AM – 11:45 AM
(2-037) Antibiotic Utilization in COVID-19 Patients
Favorite
10:45 AM – 11:45 AM
(2-038) Effect of Glucocorticoids on Insulin Use in COVID-19 Patients
Favorite
10:45 AM – 11:45 AM
(2-039) Adherence, Dose Adjustments, and Discontinuation Rates of High-Dose Deutetrabenazine in Huntington’s Disease Chorea: A Multi-Site Study
Favorite
10:45 AM – 11:45 AM
(2-040) Evaluating the Mechanistic Pathway for Activating Dendritic Cells Using Adjuvants in the Presence of Brefeldin A
Favorite
10:45 AM – 11:45 AM
(2-042) Clinical Inertia Benefits of Adding a Pharmacist to the Outpatient Collaborative Care Team in Primary Care: A Focus on Type II Diabetes Mellitus.
Favorite
10:45 AM – 11:45 AM
(2-043) Evaluation of GLP-1 RA injectable technique in a small cohort of patients
Favorite
10:45 AM – 11:45 AM
(2-044) Evaluation of Pharmacist Knowledge and Confidence in Identifying and Managing Drug-drug Interactions involving Antimicrobial Agents Before and After an Educational Intervention
Favorite
10:45 AM – 11:45 AM
(2-045) Impact of intrapartum iron sucrose therapy on postpartum hemorrhage rates: a retrospective chart review
Favorite
10:45 AM – 11:45 AM
(2-047) Readmission Rate Among Hospitalized Geriatric Patients Discharged on Beers Criteria Medications
Favorite
10:45 AM – 11:45 AM
(2-048) Assessing the Proper Use of Patient-Controlled Analgesia Before and After the Implementation of a Revised Institutional Policy
Favorite
10:45 AM – 11:45 AM
(2-049) Association of Psychological Distress with Age of First Marijuana Use
Favorite
10:45 AM – 11:45 AM
(2-050) Association of Age at First Marijuana Use with Cognitive Impairment Among Community-Dwelling Adults Aged 50 Years or Older
Favorite
10:45 AM – 11:45 AM
(2-051) Evaluating Nirmatrelvir/Ritonavir for Inpatient Treatment of COVID-19
Favorite
10:45 AM – 11:45 AM
(2-052) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Favorite
10:45 AM – 11:45 AM
(2-053) Assessment of Cyclosporine A Stability and Beyond Use Dating in Compounded Ophthalmic Solutions
Favorite
10:45 AM – 11:45 AM
(2-054) Association of Adverse Childhood Experiences with Influenza Vaccine Hesitancy
Favorite
10:45 AM – 11:45 AM
(2-055) Fostering More Capable Future Pharmacy Student Leaders: A Descriptive Report of Incorporating ASHP Student Leadership Development Program (SLDP) in a State Pharmacy Association Student Program
Favorite
10:45 AM – 11:45 AM
(2-056) Social Determinants of Health as Predictors for Optimal Health Habits
Favorite
10:45 AM – 11:45 AM
(2-057) Perceived Risk of Binge Drinking in Veterans Diagnosed with Obesity, Diabetes, or Depression
Favorite
10:45 AM – 11:45 AM
(2-058) Social Determinants of Health as a Predictor of Shared Decision-Making Regarding Prostate Specific Antigen Testing
Favorite
10:45 AM – 11:45 AM
(2-059) Sex and Race Disparities in Medication and Lifestyle Guidance Provided to Ambulatory Patients with Two or More Cardiometabolic Risk Factors
Favorite
10:45 AM – 11:45 AM
(2-060) Age at First Cannabis Use as a Predictor of Adult Heart Disease
Favorite
10:45 AM – 11:45 AM
(2-061) Examining Predictors of Erroneous Perception of Heavy Alcohol Use and Marijuana Use in Adolescents and Young Adults with Major Depressive Disorder
Favorite
10:45 AM – 11:45 AM
(2-062) Series of Computational Structures: PCIF1 Inhibitors Structural Design to Promote Therapeutic Response in Colorectal Cancer and Anti-PD-1 Immunotherapy
Favorite
10:45 AM – 11:45 AM
(2-063) Association of Psychological Distress and Psychoactive Medication Use with Cognitive Impairment in Older Adults
Favorite
10:45 AM – 11:45 AM
(2-064) Association of Adverse Childhood Experiences with Poor Functioning in Community Dwelling U.S. Adults with Myalgia
Favorite
10:45 AM – 11:45 AM
(2-065) A Pilot Study to Determine Contributing Factors of Blood Culture Contamination at Two Community Hospitals
Favorite
10:45 AM – 11:45 AM
(2-066) Targeted Medication Discharge Counseling by Pharmacists: Quality Improvement Project and Standardization of Procedures
Favorite
10:45 AM – 11:45 AM
(2-067) Immune-Related and Cutaneous Adverse Events Associated with Relatlimab Mono/Combo Regimens Versus Other Immune Checkpoint Inhibitors in Advanced, Non-Resectable Cutaneous Melanoma: Systematic Review and Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(2-068) Cost Efficiency of Trilaciclib, A First-in-Class Kinase Inhibitor Providing Multilineage Myeloprotection, and Expanded Budget-Neutral Access to Multilineage Myeloprotection for Extensive-Stage Small Cell Lung Cancer Patients
Favorite
10:45 AM – 11:45 AM
(2-069) The impact of improved patient education on response rates to automated patient intake messaging system
Favorite
10:45 AM – 11:45 AM
(2-070) Identifying discharge medication discrepancies in patients transitioning from Northwest Medical Center to long-term care
Favorite
10:45 AM – 11:45 AM
(2-071) Naloxone: A Pain to Co-Prescribe? Evaluating naloxone co-prescribing practices for patients at an increased risk of opioid overdose at a federally qualified health center.
Favorite
10:45 AM – 11:45 AM
(2-072) Evaluating the Feasibility of the Use of Diabetes Education Videos During Endocrinology Clinic Visits
Favorite
10:45 AM – 11:45 AM
(2-073) Population health pharmacotherapy optimization of sacubitril/valsartan for patients with heart failure reduced ejection fraction
Favorite
10:45 AM – 11:45 AM
(2-074) Delabeling patient allergies to penicillins in the Emergency Department: a pilot program
Favorite
10:45 AM – 11:45 AM
(2-075) Assessment of a Pediatric Quality Improvement Program in a Rural Federally Qualified Healthcare Center
Favorite
10:45 AM – 11:45 AM
(2-076) Relationship between Oxytocin, Anxiety, and Depression.
Favorite
10:45 AM – 11:45 AM
(2-077) Student-Led Pharmacy Technician Certification Review
Favorite
10:45 AM – 11:45 AM
(2-078) Evaluating the Financial Impact of Providing COVID-19 Services on Community Pharmacies in Arkansas
Favorite
10:45 AM – 11:45 AM
(2-079) Tocilizumab Use in Severe Hospitalized COVID-19 Infection
Favorite
10:45 AM – 11:45 AM
(2-080) Do Health Disparities Impact Antibiotic Utilization in Treating Pediatric Urinary Tract Infections in Critical Care
Favorite
10:45 AM – 11:45 AM
(2-081) Effect of methadone and buprenorphine for the treatment of opioid use disorder on leaving against medical advice in the inpatient setting
Favorite
10:45 AM – 11:45 AM
(2-082) Evaluating Pediatric Antimicrobial Prescribing Practices for Community Acquired Pneumonia (CAP)
Favorite
10:45 AM – 11:45 AM
(2-083) Preclinical study of hepatoprotective effects of Astragaloside-IV and Formononetin as potential treatment for chronic hepatitis
Favorite
10:45 AM – 11:45 AM
(2-084) Assessment of Pharmacist Responsibilities in California's Emergency Departments
Favorite
10:45 AM – 11:45 AM
(2-085) Implementation of Wellness Clinics in Collaboration with Pharmacists and Quality Team to Improve Quality Measures
Favorite
10:45 AM – 11:45 AM
(2-086) Impact of Pharmacist Transitions of Care Interventions in Identifying Medication Errors for Patients Discharging to a Skilled Nursing Facility
Favorite
10:45 AM – 11:45 AM
(2-087) Food Interactions in Rheumatoid Arthritis
Favorite
10:45 AM – 11:45 AM
(2-088) Pharmacists’ Participation and Role in Code Blue Situations within Hospitals in the United States
Favorite
10:45 AM – 11:45 AM
(2-089) Survey Study to Understand the Availability of Nirmatrelvir/Ritonavir in the Community Pharmacies in California
Favorite
10:45 AM – 11:45 AM
(2-090) Structure-function studies of loss-of-function KCa2.2 mutant channels
Favorite
10:45 AM – 11:45 AM
(2-091) Evaluating the Safety and Efficacy of Thrombolytic Therapies in the Treatment of Ischemic Stroke
Favorite
10:45 AM – 11:45 AM
(2-092) Risk Factors for Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Community-Acquired Pneumonia
Favorite
10:45 AM – 11:45 AM
(2-093) Efficacy and Safety of Dabigatran Compared to Apixaban and Rivaroxaban in Patients with VTE and BMI ≥40 kg/m2 and/or Weight ≥120kg
Favorite
10:45 AM – 11:45 AM
(2-094) A Meta-Analysis of the Efficacy and Safety of Bexagliflozin Versus Other Sodium-Glucose Cotransporter-2 Inhibitors
Favorite
10:45 AM – 11:45 AM
(2-095) Impact of Mental Health First Aid (MHFA) Training and Certification on Knowledge and Attitudes in Los Angeles Area Pharmacy Professionals
Favorite
10:45 AM – 11:45 AM
(2-096) Systematic Review of Alternative Therapies for the Treatment of Parasomnias
Favorite
10:45 AM – 11:45 AM
(2-097) Real-World Non-Adherence Treatment Rates of Patients with Migraine in the United States: A Targeted Literature Review
Favorite
10:45 AM – 11:45 AM
(2-098) Comparative Analysis of Treatment Changes Among Children with ADHD Initiated on Pharmacologic Therapies using Real-World Data: A Systematic Literature Review
Favorite
10:45 AM – 11:45 AM
(2-099) Evaluation of the Gene and Protein Expression Profile of the Thymic Stromal Lymphopoietin Receptor in Multiple Tumor Types
Favorite
10:45 AM – 11:45 AM
(2-100) Hemoglobin A1c Reduction by Pharmacist-Led Interventions in an Ambulatory Care Clinic
Favorite
10:45 AM – 11:45 AM
(2-101) Characterizing Vancomycin Use at a Large Academic Medical Center That Serves a High SVI Area
Favorite
10:45 AM – 11:45 AM
(2-102) Pharmacists’ Impact on Discharge Medication Reconciliation at a Comprehensive Cancer Center
Favorite
10:45 AM – 11:45 AM
(2-104) Clinical Efficacy and Safety of Systemic Antibiotics for Treatment of Acute Pyelonephritis in Adults: A Network Meta-Analysis of Randomized Controlled Trials
Favorite
10:45 AM – 11:45 AM
(2-105) Did YOU get your influenza vaccine?
Favorite
10:45 AM – 11:45 AM
(2-106) Exploring LGBT+ Cultural Competency Continuing Education and Pharmacist-Initiated HIV PrEP/PEP: A Cross-sectional Review of U.S. Pharmacy Legislation
Favorite
10:45 AM – 11:45 AM
(2-107) Self-measured Blood Pressure Monitoring in a Spanish and English Language-Concordant Setting: A Retrospective Chart Review
Favorite
10:45 AM – 11:45 AM
(2-108) Evaluating the Effect of the Timing and Sequence of Antibiotic Administration on Patient Outcomes for Sepsis and Septic Shock at Desert Valley Hospital
Favorite
10:45 AM – 11:45 AM
(2-109) Romiplostim for the Treatment of Thrombocytopenia in Hematopoietic Stem Cell Transplantation Recipients
Favorite
10:45 AM – 11:45 AM
(2-110) Evaluating the Conjunction of using both CGM and Fructosamine for Monitoring Glycemic Control in African Americans Who Have Type 2 Diabetes
Favorite
10:45 AM – 11:45 AM
(2-111) Understanding Variability in Endothelial Function Assessment Using the EndoPAT
Favorite
10:45 AM – 11:45 AM
(2-112) Labeling Animal-Derived Ingredients in Medications
Favorite
10:45 AM – 11:45 AM
(2-113) Reconciling Therapeutic Equivalence Evaluations of Solid Oral Dosage Forms and Identifying Dosage Strengths Used to Demonstrate Bioequivalence for Generic Drug Development
Favorite
10:45 AM – 11:45 AM
(2-114) Incidence and Survival Outcome of Immune Checkpoint Inhibitor-Induced Myocarditis and Pericardial Disease
Favorite
10:45 AM – 11:45 AM
(2-115) Assessment of the prevalence of potentially inappropriate medication use in older Latino adults in Los Angeles
Favorite
10:45 AM – 11:45 AM
(2-116) Assessment of the prevalence of potentially inappropriate medication use in older Latino adults in Los Angeles
Favorite
10:45 AM – 11:45 AM
(2-117) Racial/Ethnic Disparities in the Baseline Cardiovascular Risks in Patients Who Underwent Percutaneous Coronary Intervention (PCI)
Favorite
10:45 AM – 11:45 AM
(2-118) Impact of Malnourishment on Abacavir and Lamivudine Treatment in Sub-Saharan African Children Under the Age of 5
Favorite
10:45 AM – 11:45 AM
(2-119) Accuracy and Precision of Vancomycin Clearance as a Marker of Kidney Function
Favorite
10:45 AM – 11:45 AM
(2-120) National Survey of Institutional Guidelines for the Use of Ketamine, Lidocaine, and Dexmedetomidine for Refractory Pain
Favorite
10:45 AM – 11:45 AM
(2-121) Evaluation on Sugammadex Dosing in Adult Patients on Length of Post-Anesthesia Care Unit (PACU) Stay
Favorite
10:45 AM – 11:45 AM
(2-122) Association Between Immune Related Adverse Events and Overall Survival in Cancer Patients who Received Immune Checkpoint Inhibitors
Favorite
10:45 AM – 11:45 AM
(2-123) An Exploration of Magnetic Nanoparticles in Targeted Retinal Drug Delivery
Favorite
10:45 AM – 11:45 AM
(2-124) Identification of Amebicidal Marine Microbial Metabolites against Naegleria fowleri
Favorite
10:45 AM – 11:45 AM
(2-125) Qualitative Analysis of Mental Health Stressors Among Pharmacy and Medical Students
Favorite
10:45 AM – 11:45 AM
(2-126) Ethnic and Racial Analysis for Drug Approvals: Lessons from Various Regulatory Authorities and Recent FDA Approvals
Favorite
10:45 AM – 11:45 AM
(2-127) Refurbishing Drug Therapies with Neuroprotective Properties to Treat Parkinson’s Disease using In Vivo Zebrafish Model
Favorite
10:45 AM – 11:45 AM
(2-128) Assessment of Sirolimus and Antiretroviral Drug Interactions in People with HIV
Favorite
10:45 AM – 11:45 AM
(2-129) Factors Influencing Tolerability of Angiotensin Receptor/Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction (HFrEF) in the Inpatient Setting
Favorite
10:45 AM – 11:45 AM
(2-130) Prevalence of Brain-derived Neurotrophic Factor Val66Met Polymorphism (rs6265) Among Cancer Survivors with Cancer-Related Cognitive Impairment: An All of Us Study
Favorite
10:45 AM – 11:45 AM
(2-131) Association Between Self-Care Practices and Stress Level in Pharmacy Students
Favorite
10:45 AM – 11:45 AM
(2-132) Evaluating the Usage of Ruxience (rituximab-pvvr) in a Community Teaching Hospital
Favorite
10:45 AM – 11:45 AM
(2-133) Sex Differences in the Cost-related Medication Adherence in Patients with HTN, CVD and HF: An All of Us Study
Favorite
10:45 AM – 11:45 AM
(2-134) Impact of Virtual and Augmented Reality as an Emerging Technology on Pharmacy Education
Favorite
10:45 AM – 11:45 AM
(2-135) Antibiotic Use Patterns in Patients Presenting to Pediatric Emergency Department or Urgent Care for Non-Trauma Related Dental Presentations
Favorite
10:45 AM – 11:45 AM
(2-136) Clinical Outcome Comparisons Between Telehealth Visits and In-Person Visits Among Veterans Referred to a Pharmacist-Led Diabetes Management Clinic
Favorite
10:45 AM – 11:45 AM
(2-137) Effect of Pharmacy-Led Intervention Care Bundle on 30-Day HF Readmissions
Favorite
10:45 AM – 11:45 AM
(2-138) OR Compounding Use Evaluation of Heparin-Verapamil-Nitroglycerin-Sodium Bicarbonate-Lactated Ringers Solution in Patients at UCSF Health
Favorite
10:45 AM – 11:45 AM
(2-139) Alternative Tobacco Product Use Among Adults and Youth Experiencing Homelessness: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-140) Implementation of a Pharmacist-Led Antimicrobial Stewardship Program in a Pediatric Kidney Care Clinic in Guatemala
Favorite
10:45 AM – 11:45 AM
(2-141) Retail chain pharmacy opioid dispensing practices from 1997 to 2020: A content analysis of internal industry documents
Favorite
10:45 AM – 11:45 AM
(2-142) Examining the difference in Patient Outcomes at culturally focused clinics versus standard of care in Bay Area California
Favorite
10:45 AM – 11:45 AM
(2-143) MEDICATION USE EVALUATION OF ECULIZUMAB USE IN PEDIATRIC PATIENTS AT UCSF BENIOFF CHILDREN’S HOSPITALS
Favorite
10:45 AM – 11:45 AM
(2-144) Evaluating Strategies Opioid Manufacturers Use to Encourage Opioid Overprescribing
Favorite
10:45 AM – 11:45 AM
(2-145) Apixaban for Atrial Fibrillation with or without Aspirin After Transcatheter Aortic Valve Replacement
Favorite
10:45 AM – 11:45 AM
(2-146) Impact of Concomitant Oral Nucleos(t)ide Use With Bulevirtide on Treatment Outcomes in Patients with Chronic Hepatitis B/Hepatitis D Coinfection
Favorite
10:45 AM – 11:45 AM
(2-147) Cross-Sectional Study on the Relationship Between Physical Activity, Cardiovascular Disease, and Cognitive Decline
Favorite
10:45 AM – 11:45 AM
(2-148) Antimicrobial Stewardship Driven De-labeling of Penicillin Allergies
Favorite
10:45 AM – 11:45 AM
(2-149) Validating and Re-evaluating a Model for Tacrolimus in Pediatric Hematopoietic Cell Transplantation Patients
Favorite
10:45 AM – 11:45 AM
(2-150) Pharmacist furnishing of hormonal contraception in California’s Central Valley
Favorite
10:45 AM – 11:45 AM
(2-151) PET Imaging of Anti-HIV Broadly Neutralizing Antibodies (Encore Presentation)
Favorite
10:45 AM – 11:45 AM
(2-152) Preparedness of Independent Retail Pharmacies for Extreme Weather and Climate Events in Northern California.
Favorite
10:45 AM – 11:45 AM
(2-153) Tenecteplase vs Alteplase for the Treatment of Acute Ischemic Stroke
Favorite
10:45 AM – 11:45 AM
(2-154) Real-world Efficacy and Safety of Tixagevimab and Cilgavimab in Patients with Malignancies
Favorite
10:45 AM – 11:45 AM
(2-155) Impact of Fixed-Dose Compared to Weight-Based 4-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal
Favorite
10:45 AM – 11:45 AM
(2-156) Evaluation of Current Stress Ulcer Prophylaxis (SUP) Prescribing Practice in the Intensive Care Unit (ICU)
Favorite
10:45 AM – 11:45 AM
(2-157) Literature Review on Depression in Children and Adolescents: Risk Factors, Consequences and Individualizing Treatment
Favorite
10:45 AM – 11:45 AM
(2-158) Usability of Retail Pharmacy Websites in the United States
Favorite
10:45 AM – 11:45 AM
(2-159) Perceptions of Pharmacy: Analyzing University Students' Views on Pharmacist Roles and Factors to Promote the Pharmacy Profession
Favorite
10:45 AM – 11:45 AM
(2-160) Challenges impacting de-escalation of intravenous vancomycin at a community hospital
Favorite
10:45 AM – 11:45 AM
(2-161) Patient Experience in a Continuous Glucose Monitoring Trial
Favorite
10:45 AM – 11:45 AM
(2-162) Analysis of Conflicts-of-Interest in the Comprehensive Management of Angina with Nonobstructive Coronary Arteries (ANOCA) Review
Favorite
10:45 AM – 11:45 AM
(2-163) Comparison of Adverse Drug Event Data from FDA MedWatch and FDA Adverse Event Reporting System (FAERS)
Favorite
10:45 AM – 11:45 AM
(2-164) Assessing the Efficacy and Safety of Phosphatidylserine (PPS) with Artificial Intelligence (AI) Assistance: A Real-World Data Analysis Based on Consumer Product Reviews
Favorite
10:45 AM – 11:45 AM
(2-165) Effects of Nudge Coffee Bombs, M&M's, and Zero-Sugar Hershey's on Blood Glucose Levels
Favorite
10:45 AM – 11:45 AM
(2-166) Impact of Restricting Piperacillin-Tazobactam Use in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-167) Real-World Experience with Adjuvanted Recombinant Hepatitis B Vaccine Seroprotection in People Living with Human Immunodeficiency Virus
Favorite
10:45 AM – 11:45 AM
(2-168) Clinical Outcomes of Veterans Living With HIV Who Receive Antiplatelet Therapy
Favorite
10:45 AM – 11:45 AM
(2-169) Assessing the Impact of Boba Milk Tea Consumption on Gut Microbiota Composition: A Pilot Study
Favorite
10:45 AM – 11:45 AM
(2-170) Endothelial Function Assessment as a Marker for Longevity
Favorite
10:45 AM – 11:45 AM
(2-171) Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RA) for Weight loss in Non-Diabetic Patients
Favorite
10:45 AM – 11:45 AM
(2-172) Pharmacy-Led Interventions on Vancomycin Trough Monitoring in Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(2-173) Vitamin D Deficiency and Supplement Use in Graduate and Professional Students
Favorite
10:45 AM – 11:45 AM
(2-174) The Effect of COVID-19 on the ER Visit Rates of Asthmatic Children and Adolescents During 2020-2021 in the United States- A Literature Review
Favorite
10:45 AM – 11:45 AM
(2-175) A Retrospective Observational Study: Opioid Overdose Rates and Buprenorphine Distribution to Retail Pharmacies by Zip Code in California
Favorite
10:45 AM – 11:45 AM
(2-176) Analysis of Pharmacy Student Clinical Interventions in an Acute Care Internal Medicine Setting
Favorite
10:45 AM – 11:45 AM
(2-177) Impact of a Mixed Media Project in a Pharmacy International Student Summer Program
Favorite
10:45 AM – 11:45 AM
(2-178) Development of a Model of Omeprazole Pharmacokinetics in GastroPlus
Favorite
10:45 AM – 11:45 AM
(2-179) Automated Insulin Delivery (AID) use in Pregnancies Complicated by Type 1 Diabetes
Favorite
10:45 AM – 11:45 AM
(2-180) Sodium-Glucose Co-Transporter-2 Inhibitor Prescribing Patterns in Heart Failure with Reduced Ejection Fraction Patients Admitted to a Major Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-181) A systematic review to determine safety of probiotics in immunocompromised patients.
Favorite
10:45 AM – 11:45 AM
(2-182) The Importance of Administration, Transition, and Continuation of Care in Patients Receiving Long-Acting Antipsychotic Injectables in an Acute Psychiatric Hospital Settings.
Favorite
10:45 AM – 11:45 AM
(2-183) Risk Factors of Gastroparesis with Concurrent Use of GLP-1 Receptor Agonists
Favorite
10:45 AM – 11:45 AM
(2-184) Changes in Numbers of Multi-Drug Resistant Organisms over COVID-19 Era
Favorite
10:45 AM – 11:45 AM
(2-185) Doxycycline post-exposure prophylaxis: a systematic review of use and effectiveness among people at high risk of syphilis, gonorrhea and chlamydia infection
Favorite
10:45 AM – 11:45 AM
(2-186) Exploring Medication Adherence Strategies in the Context of Social Determinants: Literature Review
Favorite
10:45 AM – 11:45 AM
(2-187) Cybersecurity of Cardiac Pacemakers: Blockchain-Cloud (BcC) Architecture
Favorite
10:45 AM – 11:45 AM
(2-188) Clinical effects of goji berry consumption on eye health: a systematic review
Favorite
10:45 AM – 11:45 AM
(2-189) Optimal Dextrose Fluid Management in Hypertriglyceridemia-Induced Pancreatitis with Insulin Infusions: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-190) Ashwagandha Supplementation for Supporting Mental Health: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Favorite
10:45 AM – 11:45 AM
(2-191) Incidence of Venous Thromboembolism in Trauma Patients before and after Institution of a Venous Thromboembolisms Prophylaxis Protocol
Favorite
10:45 AM – 11:45 AM
(2-192) Medication Utilization Evaluation of Injectable Olanzapine at University of Colorado Hospital
Favorite
10:45 AM – 11:45 AM
(2-193) Prescription Medications and Physical Therapy Practice Considerations in Traumatic Brain Injury
Favorite
10:45 AM – 11:45 AM
(2-194) Comparing the Cost Effectiveness of Unit-Dose Packaging for Selected Oral Medications Between On-Site Repackaging, Repackaging Third-Party Vendor, and Direct Purchase from Wholesaler
Favorite
10:45 AM – 11:45 AM
(2-196) Analysis of Gastrointestinal Polymerase Chain Reaction (PCR) Assay Use at a Rural Colorado Hospital
Favorite
10:45 AM – 11:45 AM
(2-197) Pharmacist-led Oral Chemotherapy Adherence Program Effects on Quality of Life and Admissions in a Large Metropolitan Health System
Favorite
10:45 AM – 11:45 AM
(2-198) Assessment of the Management of Pyelonephritis in Adults and Concordance with Infectious Diseases Society of America (IDSA) Guidelines
Favorite
10:45 AM – 11:45 AM
(2-199) Review of a Multidisciplinary Esketamine Clinic for Treatment-Resistant Depression
Favorite
10:45 AM – 11:45 AM
(2-200) Medication Use Evaluation of Golytely for Indications Outside of Colonoscopy at Rose Medical Center
Favorite
10:45 AM – 11:45 AM
(2-201) Incidence and Clinical Characteristics of Euglycemic Diabetic Ketoacidosis Presentations in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-202) The Hartford Nomogram (HN) Twenty-Five Years Later: Revisiting Predicted Pharmacokinetic/Pharmacodynamic (PK/PD) Performance for Gentamicin and Tobramycin Against Pseudomonas aeruginosa
Favorite
10:45 AM – 11:45 AM
(2-203) Reducing Nuisance Medication Alerts at a Pediatric Health System
Favorite
10:45 AM – 11:45 AM
(2-204) Retrospective evaluation of an established pharmacy dosing protocol of enoxaparin in obesity at a community hospital
Favorite
10:45 AM – 11:45 AM
(2-205) Outpatient Medication Management Program impact on patient adherence
Favorite
10:45 AM – 11:45 AM
(2-206) Evaluation of Cannabis Use for Chronic Migraine Therapy in Chronic Spine Pain Patients
Favorite
10:45 AM – 11:45 AM
(2-207) Evaluation of Pharmacists’ Perceived Barriers to Administer Long-Acting Injectable Cabotegravir for HIV PrEP.
Favorite
10:45 AM – 11:45 AM
(2-208) Evaluation of Opioid Education and Naloxone Distribution by Transitions of Care Pharmacy Service for Discharging Patients at an Academic Teaching Hospital.
Favorite
10:45 AM – 11:45 AM
(2-209) Reasons for parental influenza vaccination declination for pediatric inpatients
Favorite
10:45 AM – 11:45 AM
(2-210) Describing current vasoplegia therapeutic management (diagnosis and treatment practices) at an academic medical center
Favorite
10:45 AM – 11:45 AM
(2-212) Balancing the Scales: A Weight Based Approach to Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(2-213) Evaluation of Hypoglycemic Events Related to Inpatient Glucocorticoid De-escalation and Insulin Use for Patients in Acute Inpatient Care
Favorite
10:45 AM – 11:45 AM
(2-214) Number of Patients Affected by the Practice of White Bagging Gonadotropin-releasing Hormone (GnRH) Agonists Over One Year in a Non-Profit Pediatric Health System
Favorite
10:45 AM – 11:45 AM
(2-215) Characterization of Off-Label Outpatient Medication Use in Children with Medical Complexity
Favorite
10:45 AM – 11:45 AM
(2-216) Staphylococcus aureus bloodstream infection outcomes among patients receiving daptomycin and methadone
Favorite
10:45 AM – 11:45 AM
(2-217) Pharmacist Deeds for Critical Needs: Effects of Pharmacist Intervention on Medication Preservation During Hydrocortisone Shortage
Favorite
10:45 AM – 11:45 AM
(2-218) Comparing Activated Partial Thromboplastin Time versus Anti-Factor Xa Monitoring for Intravenous Heparin Infusions via Nursing-Driven Network Protocols
Favorite
10:45 AM – 11:45 AM
(2-219) Analysis of Nicardipine Infusion Titration Approaches in an Acute Care Setting
Favorite
10:45 AM – 11:45 AM
(2-220) Vancomycin: Impact of Protocol Changes on Incidence of Acute Kidney Injury
Favorite
10:45 AM – 11:45 AM
(2-221) Evaluation of Pharmacist-Driven Pre-Transplant Vitamin D Supplementation Protocol in Liver Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-222) Appendicitis: A Hidden Danger of GLP-1 Receptor Agonists?
Favorite
10:45 AM – 11:45 AM
(2-223) Process and Workflow of Student Team in Developing a Drug Monograph and Formulary Placement Recommendation for Pharmacy & Therapeutics Competition
Favorite
10:45 AM – 11:45 AM
(2-224) Evaluation of Heparin and Hydrocortisone Additives in Peripheral Anti-Thymocyte Globulin (Rabbit) Infusions on Local Infusion Reactions in Renal Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(2-225) Impact of Blender Type on Tribocharging in Pharmaceutical Powders Using Surface Modified V-Blender
Favorite
10:45 AM – 11:45 AM
(2-226) Integration of Antibiotic Recommendations for Patients with β-lactam Allergies into a Cellulitis Order Set
Favorite
10:45 AM – 11:45 AM
(2-227) Real-world Concordance with Evidence-based Guidelines for First Line Metastatic HR+, HER2- Breast Cancer across the Yale New Haven Health System
Favorite
10:45 AM – 11:45 AM
(2-228) Evaluating Proper Amiodarone Loading during Admission and Discharge in Patients across a Health System
Favorite
10:45 AM – 11:45 AM
(2-229) Pharmacist-Driven Initiative to Increase Compliance with Institute for Safe Medication Practices (ISMP) Guidelines and Prevent Infusion-Related Medication Errors
Favorite
10:45 AM – 11:45 AM
(2-230) Highlighting a Collaborative Experiential Pharmacy Technician Education and Training Program among a State Pharmacy Organization, Community College, and Healthcare System.
Favorite
10:45 AM – 11:45 AM
(2-231) Evaluation of High Fidelity Simulation in a Third Year, Clinical Toxicology Pharmacy Course
Favorite
10:45 AM – 11:45 AM
(2-232) High-Dose Intravenous Fosphenytoin in a Morbidly Obese Male
Favorite
10:45 AM – 11:45 AM
(2-233) Electronic Communication Between Pharmacists and Other Professionals in the Provision of Patient Care: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(2-234) Assessment of Andexxa Use Within a Hospital System in Connecticut
Favorite
10:45 AM – 11:45 AM
(2-235) Utilization of Patient Outreach and Educational Materials to Improve Health Education and Literacy in a Rural and Underserved Population
Favorite
10:45 AM – 11:45 AM
(2-236) Mental Health Risk Factors Among Young Adults in Higher Education
Favorite
10:45 AM – 11:45 AM
(2-237) Assessing the appropriateness of low intensity statin usage
Favorite
10:45 AM – 11:45 AM
(2-238) Analyzing the Views and Perceived Roles of Pharmacists Following the Approval of Naloxone (Narcan) by the FDA for Over-the-Counter Use
Favorite
10:45 AM – 11:45 AM
(2-239) Impact of a Clinical Pharmacist on the Monitoring of Antipsychotic-Induced Metabolic Side Effects
Favorite
10:45 AM – 11:45 AM
(2-240) Assessing Knowledge, Perceived Diabetes Risk, and Barriers Among College Students
Favorite
10:45 AM – 11:45 AM
(2-241) Assessing Knowledge, Attitudes, and Perceptions Towards Human papillomavirus (HPV) Vaccination Among College Students
Favorite
10:45 AM – 11:45 AM
(2-242) Long-acting Injectable Antipsychotics’ Effect on the Rate of Acute Care Hospital Readmissions in Comparison to Oral Antipsychotics
Favorite
10:45 AM – 11:45 AM
(2-243) Identifying barriers and facilitators of pre-exposure prophylaxis (PrEP) uptake among African American and Latino populations.
Favorite
10:45 AM – 11:45 AM
(2-244) Evaluating the relationship between Medicaid expansion status and Hep ElimiNATION capacity rubric scores
Favorite
10:45 AM – 11:45 AM
(2-245) Safety, Effectiveness, and Cost of Sodium-Glucose Cotransporter-2 Inhibitors in Comparison with Glucagon-Like Peptide-1 Agonists on Weight Loss: A Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(2-246) Evaluation of Sub-Dissociative Ketamine Use in the Emergency Department of a Large Community Health Care System
Favorite
10:45 AM – 11:45 AM
(2-247) Assessment of Community-Acquired Aspiration Pneumonia Antibiotic Treatment in the Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(2-248) Evaluation of Sugammadex Dosing in Post-Operative Patients for Timely Reversal of Neuromuscular Blocker Agents
Favorite
10:45 AM – 11:45 AM
(2-249) Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
Favorite
10:45 AM – 11:45 AM
(2-250) SGLT2 Inhibitors as Potential Anticancer Agents
Favorite
10:45 AM – 11:45 AM
(2-251) Effects of Social Media in Recognizing Individual Mental Health Symptomatology When Comparing Self-Assessment and Professional Diagnosis
Favorite
10:45 AM – 11:45 AM
(2-252) Evaluation of Postoperative Opioid Use in Cesarean Section Patients Receiving Neuraxial Morphine Sulfate Versus Locally Infiltrated Liposomal Bupivacaine: A Retrospective Study
Favorite
10:45 AM – 11:45 AM
(2-253) Assessment of discrepancies during admission medication history and reconciliation process in a community hospital system
Favorite
10:45 AM – 11:45 AM
(2-254) Evaluation of an interchange program for intravenous biosimilar products at a community hospital
Favorite
10:45 AM – 11:45 AM
(2-255) Mobile Application-Based Collaborative Practice Agreement to Monitor and Manage Chronic Heart Failure Patients
Favorite
10:45 AM – 11:45 AM
(2-256) New Breakthrough in Alzheimer’s Treatment: A Review of Literature on Lecanemab
Favorite
10:45 AM – 11:45 AM
(2-257) Assessing the Incidence of Inpatient Hypoglycemic Events in Adult Diabetics Following a Reduction in Home Basal Insulin Dosage
Favorite
10:45 AM – 11:45 AM
(2-259) The Evaluation of DKA Insulin Protocol at Broward Health Hospitals
Favorite
10:45 AM – 11:45 AM
(2-260) Ritlecitinib and Baricitinib: A Review of New Immunotherapy Options for Alopecia Areta
Favorite
10:45 AM – 11:45 AM
(2-261) Evaluating the Role of Ketogenic Diet in Adults with Status Epilepticus
Favorite
10:45 AM – 11:45 AM
(2-262) Translation Software Device for Communication Barriers between Pharmacists and Patients
Favorite
10:45 AM – 11:45 AM
(2-263) The Impact of Insulin Biosimilars on Diabetes Care: A Review
Favorite
10:45 AM – 11:45 AM
(2-264) Enhancing Medication Safety: Optimizing the Process for the Addition of New Barcodes into the Medication Use System
Favorite
10:45 AM – 11:45 AM
(2-265) InsuLINK: Enhancing Insulin Adherence for Optimal Diabetes Management
Favorite
10:45 AM – 11:45 AM
(2-266) Evaluating the role of sodium-glucose cotransporter-2 inhibitors in the management of acute decompensated heart failure
Favorite
10:45 AM – 11:45 AM
(2-267) Surveillance of Pharmacists interventions in acute management of dysphagia in stroke patients
Favorite
10:45 AM – 11:45 AM
(2-268) Chlorthalidone and Hydrochlorothiazide Use Trends Amongst Hypertensive Adults on Diuretics
Favorite
10:45 AM – 11:45 AM
(2-270) Evaluating the Need for a Universal Dosing Tool in the Pediatric Population
Favorite
10:45 AM – 11:45 AM
(2-271) Trends of sleep medication use among adults with sleep disturbances: National Health and Nutrition Examination Survey (NHANES) 2009 – 2018
Favorite
10:45 AM – 11:45 AM
(2-272) Relationship Between Glucagon-Like Peptide-1 Receptor Agonist Use and the Development of Delayed Gastric Emptying-Related Complications During General Anesthesia: A Retrospective Cohort Chart Review
Favorite
10:45 AM – 11:45 AM
(2-273) Assessing the Prevalence of Mental Health Issues Among Pharmacy Students
Favorite
10:45 AM – 11:45 AM
(2-274) Investigating the Place of Sodium-Glucose Cotransporter-2 Inhibitors and Dual Sodium-Glucose Cotransporter-1 and -2 Inhibitors in Heart Failure Therapy: A Systematic Review of the Literature
Favorite
10:45 AM – 11:45 AM
(2-275) Real World Evidence of Trends in Use of Benzodiazepines in the Published Literature.
Favorite
10:45 AM – 11:45 AM
(2-276) Exploring Muscarinic Ligand-Mediated Regulation of Mitochondrial Function via CHRM1: Implications for Alzheimer's Disease Therapeutics.
Favorite
10:45 AM – 11:45 AM
(2-277) Opioids for Painful Conditions: An Evaluation of Usage in Existing Observational Studies
Favorite
10:45 AM – 11:45 AM
(2-278) Medication Use Evaluation of Adult Vancomycin Dosing in Obese Patients
Favorite
10:45 AM – 11:45 AM
(2-279) Polypharmacy and Falls in the Elderly: A Literature Review and Meta Analysis
Favorite
10:45 AM – 11:45 AM
(2-280) Evaluating Pharmacist Confidence and Willingness to Engage in Collaborative Practice Agreements and Provide Point-of-Care Testing (POCT)
Favorite
10:45 AM – 11:45 AM
(2-281) Assessment of the Adherence to a Levalbuterol Nebulized Solution Restricted Formulary Protocol in a Community Health System
Favorite
10:45 AM – 11:45 AM
(2-282) Optimizing a medication reconciliation quality assurance process at a community hospital system
Favorite
10:45 AM – 11:45 AM
(2-283) Evaluating the need for post discharge follow up at a community hospital
Favorite
10:45 AM – 11:45 AM
(2-284) Retrospective evaluation of adherence to Cleveland Clinic vasopressin dosing protocol in adults with septic shock.
Favorite
10:45 AM – 11:45 AM
(2-285) Evaluation of Agitation Post ICU-Discharge from the Discontinuation of Long-Term Fentanyl Infusion
Favorite
10:45 AM – 11:45 AM
(2-286) The impact of remote patient monitoring in addressing social determinants of health in patient outcomes.
Favorite
10:45 AM – 11:45 AM
(2-287) Assessment of the Pharmacist-Led Telephone Outreach Program for the Opioid Overdose Education and Naloxone Initiative
Favorite
10:45 AM – 11:45 AM
(2-288) Patient Satisfaction with a Pharmacist-led Pharmacogenetic Consult Clinic
Favorite
10:45 AM – 11:45 AM
(2-289) Evaluating the Safety of Inpatient Sodium Glucose Co-transporter Inhibitors Use in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-290) Evaluation of Prescribing Patterns and Appropriate Use of Albumin 5% and 25% Solutions in the Medical Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(2-291) Retrospective Descriptive Analysis on the Reduction of Hospital Length of Stay and Cost Saving of Transitioning SARS-CoV-2 Positive Inpatients to Oral Nirmatrelvir-Ritonavir.
Favorite
10:45 AM – 11:45 AM
(2-292) Iron Sucrose Infusion Reaction Management in Non-Malignant Hematology/Oncology Patients
Favorite
10:45 AM – 11:45 AM
(2-293) Beyond The Binary: Advancing Equitable Care for LGBTQ+ Cancer Patients
Favorite
10:45 AM – 11:45 AM
(2-294) Sodium-Glucose Transporter-2 Inhibitor Induced Euglycemic Diabetic Ketoacidosis
Favorite
10:45 AM – 11:45 AM
(2-295) ADC Stocking Schedule and Inventory Management Optimization Improves Inpatient Medication Availability
Favorite
10:45 AM – 11:45 AM
(2-296) Beta-Lactam Use in Penicillin Allergy
Favorite
10:45 AM – 11:45 AM
(2-297) Impact of Enhanced Contact on Time-in-Therapeutic Range in Self-Testing Warfarin Patients with Home Point-of-Care International Normalized Ratio Devices
Favorite
10:45 AM – 11:45 AM
(2-298) Descriptive Analysis of Breast Cancer Patients with GatorPGX Testing Receiving Tamoxifen or Aromatase Inhibitors
Favorite
10:45 AM – 11:45 AM
(2-299) Evaluation of the Centers for Medicare and Medicaid Services (CMS) severe hypoglycemia electronic clinical quality measure (eCQM) for adult patients at a community hospital system
Favorite
10:45 AM – 11:45 AM
(2-300) Evaluation of Prescriber Responses to Thiopurine Methyltransferase (TPMT) Pre-Test Alerts at University of Florida Health Shands Hospital
Favorite
10:45 AM – 11:45 AM
(2-301) Clozapine Risk Evaluation and Mitigation Strategy Program Adherence at a Large Health-Care System
Favorite
10:45 AM – 11:45 AM
(2-302) Evaluation of MRSA nares testing for predicting MRSA diabetic foot infections
Favorite
10:45 AM – 11:45 AM
(2-303) Blood Product Sparing Effect of Preoperative Vitamin K Administration in Cardiac Surgery
Favorite
10:45 AM – 11:45 AM
(2-304) Assessing the Efficacy and Safety of Ibutilide for Pharmacologic Cardioversion to Normal Sinus Rhythm
Favorite
10:45 AM – 11:45 AM
(2-305) Association between Triptan Use and Cardiovascular Disease and All-Cause Mortality among Patients with Migraine: A Systematic Review and Meta-analysis
Favorite
10:45 AM – 11:45 AM
(2-306) Cost-Savings Analysis of Inpatient Inhaler to Nebulizer Therapeutic Interchange
Favorite
10:45 AM – 11:45 AM
(2-307) Evaluation of the Teratogenic Effects of Sulfamethoxazole/Trimethoprim: A Comprehensive Literature Review
Favorite
10:45 AM – 11:45 AM
(2-308) Evaluation of Azithromycin Use for Community Acquired Pneumonia and COPD Exacerbation in a Large Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-309) Time to 4F-PCC and associated outcomes when compounded bedside versus in central pharmacy
Favorite
10:45 AM – 11:45 AM
(2-310) Frequency and Timing of Lipid Labs for the Management of Type 2 Diabetes in American Indian Adults Compared to Practice Guidelines
Favorite
10:45 AM – 11:45 AM
(2-311) Medication Use Evaluation of Community-Acquired Pneumonia Guideline Compliance in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-312) Evaluation of the Efficacy and Outcomes of Single vs. Standard Dosing of Basiliximab in Lung Transplantation
Favorite
10:45 AM – 11:45 AM
(2-313) Evaluating the Use of Valganciclovir in the Prevention of CMV in Post-Kidney Transplant Patients and the Incidences of CMV Outbreak During Antiviral Therapy
Favorite
10:45 AM – 11:45 AM
(2-314) Evaluation of Lidocaine Infusion Use in a Large Community Teaching Hospital
Favorite
10:45 AM – 11:45 AM
(2-315) Incidence of hypotension in obese trauma patients receiving propofol in the emergency department
Favorite
10:45 AM – 11:45 AM
(2-316) Evaluation of Dental Kits Processes in an Emergency Department for Dental Caries
Favorite
10:45 AM – 11:45 AM
(2-317) Assessment of Pharmacological Management for Agitation Through Use of a Behavioral Health Orderset in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-318) Evaluation of Opioid Prescribing Disparities in Black Patients with Nephrolithiasis: A TriNetX Retrospective Cohort Study
Favorite
10:45 AM – 11:45 AM
(2-319) Evaluation of Prophylactic Enoxaparin Use in Extreme Body Weights
Favorite
10:45 AM – 11:45 AM
(2-320) Evaluation of Empiric Antibiotic Selection and Guideline Concordance for Treatment of Inpatient Community-Acquired Pneumonia
Favorite
10:45 AM – 11:45 AM
(2-321) Effect of Metformin on Depressive Episodes in Individuals with Major Depressive Disorder: A Retrospective Cohort Study
Favorite
10:45 AM – 11:45 AM
(2-322) Increasing Utilization of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors in Congestive Heart Failure Patients
Favorite
10:45 AM – 11:45 AM
(2-323) Caught in the Swell: Alteplase and ACE-inhibitor-Induced Angioedema – A Case Report
Favorite
10:45 AM – 11:45 AM
(2-324) Evaluating the Role of Buprenorphine Patch in the Treatment of Malignant Pain
Favorite
10:45 AM – 11:45 AM
(2-325) Assessment of Provider Knowledge and Therapeutic Approaches for Reducing Stroke Risk in Patients with Nonvalvular Atrial Fibrillation
Favorite
10:45 AM – 11:45 AM
(2-326) Attainment of Target Vancomycin Trough in Patients with Cutaneous Burn Injury and/or Inhalation Injury at a Regional Burn Center
Favorite
10:45 AM – 11:45 AM
(2-327) Use of Sodium Glucose Co-transporters (SGLT2) Inhibitors in Heart Failure Patients
Favorite
10:45 AM – 11:45 AM
(2-328) Evaluating Appropriate Iron Replacement for Epoetin Alfa Doses at St. Joseph’s Hospital
Favorite
10:45 AM – 11:45 AM
(2-329) Demographic Reporting and Subgroup Analysis: A Study on Premarketing Trials of SGLT2 Inhibitors
Favorite
10:45 AM – 11:45 AM
(2-330) Characterization of Lung Transplant Recipients and Outcomes in Treatment of De Novo DQ Antibodies
Favorite
10:45 AM – 11:45 AM
(2-331) Pharmacists Ratings of Factors Considered Important in Dispensing Opioid Medication
Favorite
10:45 AM – 11:45 AM
(2-332) Abemaciclib linkage to care: a health system specialty pharmacy initiative
Favorite
10:45 AM – 11:45 AM
(2-333) Evaluation of inflammatory bowel disease treatment discontinuation rates in patients within health system specialty pharmacy
Favorite
10:45 AM – 11:45 AM
(2-334) Characterization of Copper Deficiency in Adults with Liver Diseases
Favorite
10:45 AM – 11:45 AM
(2-335) Direct-acting Antiviral for Treatment of Donor-derived Hepatitis C Virus Infection After Liver Transplant
Favorite
10:45 AM – 11:45 AM
(2-336) A Medication Use Evaluation of Enoxaparin in Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(2-337) Evaluation of Electronic Clinical Decision Support using the Caprini Risk Assessment Model for VTE prophylaxis in Hospitalized Medical Patients
Favorite
10:45 AM – 11:45 AM
(2-338) Assessing the Appropriate Use of Linezolid in Patients with Hospital-Acquired Pneumonia and Ventilator-Acquired Pneumonia in the Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(2-339) Evaluation of Hypoglycemia with Insulin Dosing for the Treatment of Hyperkalemia
Favorite
10:45 AM – 11:45 AM
(2-340) Respiratory syncytial virus (RSV) Vaccine Prescribing in an Outpatient Internal Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(2-341) Evaluating the rate of circuit filter clotting during continuous renal replacement therapy in critically ill patients receiving subtherapeutic anticoagulation
Favorite
10:45 AM – 11:45 AM
(2-342) Potential Euglycemic Diabetic Ketoacidosis (DKA) Due to Sodium-Glucose Transport Protein 2 (SGLT-2) Inhibitor Use in a Critically Ill Patient
Favorite
10:45 AM – 11:45 AM
(2-343) Real-World Analysis of Inpatient Guideline-Directed Medical Therapy Management for Chronic Heart Failure
Favorite
10:45 AM – 11:45 AM
(2-344) Investigating the Impact of Lactose-Containing Medications on Patients with Lactose Intolerance
Favorite
10:45 AM – 11:45 AM
(2-345) Continuous Glucose Monitoring in Chronic Uncontrolled Diabetes Mellitus: Significant Clinical Effect on Patient Engagement and Medication Adherence
Favorite
10:45 AM – 11:45 AM
(2-346) Exploring the Interplay between Nutrition, Gut Microbiota, and Alzheimer's Disease: Insights into the Gut-Brain Axis and Mechanisms Linking Bacteria to Pathogenesis
Favorite
10:45 AM – 11:45 AM
(2-347) Sodium-Glucose Cotransporters 2 Inhibitors in Heart Failure Patients: Significant Clinical Effect on Masking Blood Glucose and Causing Euglycemic Diabetic Ketoacidosis
Favorite
10:45 AM – 11:45 AM
(2-348) Risk-Benefit Analysis of Catheter Lock Solutions in Patients with Central Parenteral Nutrition Dependency
Favorite
10:45 AM – 11:45 AM
(2-350) Lisinopril-Induced Small Bowel Angioedema Presenting as Abdominal Pain - A Unique Case Report
Favorite
10:45 AM – 11:45 AM
(2-351) Breaking Barriers: Fostering Health Equity through Underrepresented Minority Pharmacy Student Training in PCN Allergy Assessment and Skin Testing
Favorite
10:45 AM – 11:45 AM
(2-352) Assessment of Appropriate Sugammadex Use in Two Outpatient Surgical Centers
Favorite
10:45 AM – 11:45 AM
(2-353) Relationship Between Glycemic Control and Weight Loss with Tirzepatide Injection, The First and Only Dual GIP/GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes
Favorite
10:45 AM – 11:45 AM
(2-354) In vitro high throughput screening of anthraquinone derivatives for the inhibitory effect against SARS-CoV-2 proteolytic enzymesCoV-2 proteolytic enzymes
Favorite
10:45 AM – 11:45 AM
(2-355) Alternatives to Opioid Use as Pain Management in Sickle Cell Disease in Pediatrics
Favorite
10:45 AM – 11:45 AM
(2-356) Recently Reported Side Effects and Drug Interactions of Antifungals
Favorite
10:45 AM – 11:45 AM
(2-357) Exploring the Efficacy of Delta-9-tetrahydrocannabinol (THC) Transdermal Patches in Essential Tremor Management
Favorite
10:45 AM – 11:45 AM
(2-358) Cannabis for the Treatment of Postherpetic Neuralgia
Favorite
10:45 AM – 11:45 AM
(2-359) Assessing the impact of decompressing pharmacy school curriculum on students diabetes knowledge in an accelerated pharmacy school program
Favorite
10:45 AM – 11:45 AM
(2-360) Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor-Related Euglycemic Diabetic Ketoacidosis.
Favorite
10:45 AM – 11:45 AM
(2-361) Evaluation of the Impact of the Inhibition of the Renin–Angiotensin–Aldosterone System on COVID-Related Neurologic Dysfunction
Favorite
10:45 AM – 11:45 AM
(2-362) Findings from a statewide needs assessment survey of people with HIV 50 years and older: Direct and indirect indicators of medication adherence
Favorite
10:45 AM – 11:45 AM
(2-363) State-level assessment of diabetes-related morbidity and mortality rates based upon Medicaid coverage of continuous glucose monitors
Favorite
10:45 AM – 11:45 AM
(2-364) Sex-Specific Disparities in Pain Management of Acute Unspecified Abdominal Pain
Favorite
10:45 AM – 11:45 AM
(2-365) Medication Use Analysis of Oral Oncologic Agents at Inpatient Transtion
Favorite
10:45 AM – 11:45 AM
(2-366) Factors influencing contraceptive use in women living with HIV/AIDS in the USA and Cameroon.
Favorite
10:45 AM – 11:45 AM
(2-367) Evaluating the Incorporation of Learning Style in Student Pharmacist Knowledge Retention of Enteral and Parenteral Nutrition in Critically Ill Patients
Favorite
10:45 AM – 11:45 AM
(2-368) Impact of the COVID-19 Pandemic on the Risk Factors and Outcomes for Candidemia
Favorite
10:45 AM – 11:45 AM
(2-369) Evaluation of Timing of Surgical Antibiotic Prophylaxis and the Risk of Surgical Site Infection
Favorite
10:45 AM – 11:45 AM
(2-370) Evaluation of Asymptomatic Bacteriuria Treatment for Patients Admitted to a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-371) Evaluate the Use of the Automatic Calculation via Computerized Provider Order Entry of Adjusted Body Weight for Acyclovir Injection Dosing
Favorite
10:45 AM – 11:45 AM
(2-372) Evaluation of the Impact of the Respiratory Pathogen Panel on Changes in Antimicrobial Regimen
Favorite
10:45 AM – 11:45 AM
(2-373) Assessment of the Enoxaparin Prescribing Following the CHEST Periprocedural Guideline Update
Favorite
10:45 AM – 11:45 AM
(2-374) Assessing Medication Usage and Financial Burden in Alzheimer's and Dementia Patients: A Retrospective Study
Favorite
10:45 AM – 11:45 AM
(2-375) A Comparison of Patient Assistance Approvals During and Post-SARS-CoV-2 at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-376) Perioperative Management of Patients who have Interrupted their Antithrombotic Therapy without Provider Permission
Favorite
10:45 AM – 11:45 AM
(2-377) Evaluation of Pharmacy Student Empathy toward Patients Living with Alzheimer’s Disease and Related Dementias and Caregivers Following a Dementia Simulation
Favorite
10:45 AM – 11:45 AM
(2-378) Evaluation of a Pulmonary Embolism in a 21-year-old African American Male with Tetralogy of Fallot and Secondary Complications
Favorite
10:45 AM – 11:45 AM
(2-379) Pharmacy Quality Improvement Initiative in an Interprofessional Field Clinic for Rural South Georgia Farmworkers
Favorite
10:45 AM – 11:45 AM
(2-380) Aminophylline Dosing in Electroconvulsive Therapy
Favorite
10:45 AM – 11:45 AM
(2-381) Investigating the Correlation between Hepatitis C Cure and Improvement of Hemoglobin A1c in Type II Diabetes Mellitus
Favorite
10:45 AM – 11:45 AM
(2-382) Clinical Assessment to Lower Migraines (CALM): Implementing Population Health Management for Migraine Patients in a Health System Specialty Pharmacy (HSSP) Setting
Favorite
10:45 AM – 11:45 AM
(2-383) Time to Readmission After Positive Blood Cultures in Patients Discharged from the Emergency Department
Favorite
10:45 AM – 11:45 AM
(2-384) Impact of Insurance Status on LDL-C Treatment Threshold Achievement in Patients with Atherosclerotic Cardiovascular Disease
Favorite
10:45 AM – 11:45 AM
(2-385) Assessing Second-Year Pharmacy Students’ Longitudinal Improvement in Identifying Medication-Related Problems (MRPs) After Introducing a Medication-Related Problem Detection Tool (MRPDT)
Favorite
10:45 AM – 11:45 AM
(2-386) Evaluation of Levetiracetam Loading Doses in Management of Status Epilepticus in the Emergency Setting at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-387) Retrospective Study of Patients ≥ 65 years old with Type 2 Diabetes Mellitus and the Characteristics associated with Sulfonylurea Utilization
Favorite
10:45 AM – 11:45 AM
(2-388) Antiretroviral Use Among Hospitalized Adult Patients at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-389) State Association Engagement: Benefits and Challenges Affecting Chain Community Pharmacists
Favorite
10:45 AM – 11:45 AM
(2-390) Impact of Pharmacist Involvement on Vaccination Rates in Pediatric Kidney Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-391) Characterization of the Contributions of Women Pharmacists to Critical Care Scholarship
Favorite
10:45 AM – 11:45 AM
(2-392) Evaluation of Gastrointestinal Polymerase Chain Reaction Assays and Duration of Antimicrobial Therapy in the Inpatient Setting
Favorite
10:45 AM – 11:45 AM
(2-393) Effect of reversal agents for Xa-inhibitor associated GI bleeds
Favorite
10:45 AM – 11:45 AM
(2-394) Assessment of Pharmacy Student Confidence in Meeting Accreditation Council for Pharmacy Education (ACPE) Standards Prior to Advanced Pharmacy Practice Experiences
Favorite
10:45 AM – 11:45 AM
(2-395) Steroid Use in a Neonatal Intensive Care Unit (NICU) at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(2-396) Evaluation of Antibiotic Prescribing Practices in Adults with Acute Respiratory Tract Infections
Favorite
10:45 AM – 11:45 AM
(2-397) Variceal Bleeding Treatment Optimization After Implementation of Orderset
Favorite
10:45 AM – 11:45 AM
(2-398) Durations of Antimicrobial Therapy Following Removal of Automatic Stop Dates
Favorite
10:45 AM – 11:45 AM
(2-399) Risk Assessment of Falls in Hematologic Malignancy and Hematopoietic Cell Transplant Patients
Favorite
10:45 AM – 11:45 AM
(2-400) Comparing Processing Times of Remifentanil Dispensed from Central Pharmacy Versus Automated Dispensing Machines at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(2-401) Categorization of Drug Information Questions Asked by Physicians and Medical Residents in a Rural Family Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(2-402) Peer-Reviewed Publication Rates Among Pharmacy Practice Faculty at Private Colleges and Schools of Pharmacy in the United States
Favorite
10:45 AM – 11:45 AM
(2-403) Evaluation of Oral Antibiotic Prescribing Patterns at Hospital Discharge
Favorite
10:45 AM – 11:45 AM
(2-404) Evaluation of Patient Compliance with Nystatin for Oropharyngeal Candidiasis Prophylaxis Following Kidney Transplant
Favorite
10:45 AM – 11:45 AM
(2-405) Investigation into Health Factors of Four Rural Georgia Counties Influencing Poor Health Oucomes
Favorite
10:45 AM – 11:45 AM
(2-406) Evaluating the Health Outcomes of Four Counties in Rural Georgia Compared to State Averages and Top U.S. Performers
Favorite
10:45 AM – 11:45 AM
(2-407) Assessment of Comfort in Providing Fentanyl Test Strip Counseling in Georgia Community Pharmacies
Favorite
12:00 PM – 1:00 PM
Student Posters
12:00 PM – 1:00 PM
(3-005) Comparison of weight loss diabetic medication prescribing and self-reported obesity prevalence rates in the United States in 2021
Favorite
12:00 PM – 1:00 PM
(3-006) Improving Pharmacy Students’ Awareness and Empathy Through a Lifestyle Tracking Program
Favorite
12:00 PM – 1:00 PM
(3-007) Comparison of Fidaxomicin and Oral Vancomycin Prescribing and Cost with Rates of Hospital Acquired Clostridium Difficile Infections in the United States, 2021
Favorite
12:00 PM – 1:00 PM
(3-008) Synthetic Opioid Deaths in Hawaii Compared to the Nation From 2016 to 2022
Favorite
12:00 PM – 1:00 PM
(3-009) Use of Beyond Max Dosing of Antiepileptic Drugs for Status Epilepticus
Favorite
12:00 PM – 1:00 PM
(3-010) Analyzing US FDA-Approved Infectious Disease Drugs from 2015-2023
Favorite
12:00 PM – 1:00 PM
(3-011) Identifying Hepatitis C in Patients with Opioid-Associated Diagnoses for Enrollment into Pharmacist-Led Hepatitis C Management Program
Favorite
12:00 PM – 1:00 PM
(3-012) Optimizing Heart Failure Care: A Retrospective Analysis of GDMT Adherence at East Hawaii Health Clinic
Favorite
12:00 PM – 1:00 PM
(3-013) Severity of Veterans’ Disability Rating Associated with Sociodemographic Characteristics
Favorite
12:00 PM – 1:00 PM
(3-014) Evaluation of the Effectiveness and Need for Pharmacist Intervention of Direct Oral Anticoagulants
Favorite
12:00 PM – 1:00 PM
(3-015) Comparison of budesonide/formoterol and albuterol prescribing trends to asthma-related hospitalization and mortality rates from 2018-2020
Favorite
12:00 PM – 1:00 PM
(3-016) Examining US FDA Approved Central Nervous System Drugs from 2015-2023
Favorite
12:00 PM – 1:00 PM
(3-017) Price Comparison of Popular Online Pharmacies to Walmart’s Generic Discount Prescription Program
Favorite
12:00 PM – 1:00 PM
(3-018) Health Care Coverage Disparities Among Native Hawaiian, Filipino, and Chinese Populations in Hawaii and Elsewhere in the United States
Favorite
12:00 PM – 1:00 PM
(3-019) Pharmacy Students' Perspectives on the Impact of Social Media in Educational Settings
Favorite
12:00 PM – 1:00 PM
(3-020) Potential Drug-Drug Interactions of COVID-19 Antivirals Detected by Four Databases
Favorite
12:00 PM – 1:00 PM
(3-021) Comparison of Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Transport Protein 2 Inhibitor Prescription Rates and Mortality in the US in 2020
Favorite
12:00 PM – 1:00 PM
(3-022) 2017 National MRSA Hospital Associated Infection Rates Compared to Medicare Bactrim and Doxycycline Prescriptions
Favorite
12:00 PM – 1:00 PM
(3-023) 2020 Diabetes Deaths and Medicare Statin Prescription Rates
Favorite
12:00 PM – 1:00 PM
(3-024) Impact of Pharmacist and Nurse Driven Post-Discharge Phone Call Follow-Ups and Medication-Related Hospital Readmissions at Kaiser Permanente Hawaii: A Retrospective Review of Patient Charts
Favorite
12:00 PM – 1:00 PM
(3-025) Assessment of Pharmacy Student Knowledge Before and After a Three-Hour Medicare Training Session
Favorite
12:00 PM – 1:00 PM
(3-026) Impact of a Pharmacist-Driven Protocol Aimed at Optimizing Perioperative Usage of Cefazolin, Vancomycin and Clindamycin in Patients with Documented Penicillin and Cephalosporin Allergies
Favorite
12:00 PM – 1:00 PM
(3-027) Telehealth drug therapy management with MOUD (Medications for opioid use disorder)
Favorite
12:00 PM – 1:00 PM
(3-028) Pharmacy-Led Nursing Competency Training on a Calcium Channel Blocker and Beta-Blocker Overdose Order Set in a Community Hospital Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-029) The Readability and Credibility of Online Information about Prediabetes
Favorite
12:00 PM – 1:00 PM
(3-030) Increasing health equity through identifying and connecting female Veterans with diabetes without statin therapy with clinical pharmacist practitioners
Favorite
12:00 PM – 1:00 PM
(3-031) Impact of a Pharmacist Heart Failure Monitoring Service in an Inpatient Setting
Favorite
12:00 PM – 1:00 PM
(3-032) Patient Outcomes when managing Atrial Fibrillation with Rapid Ventricular Response with Continuous IV Infusion versus Oral Immediate-Release Diltiazem in the Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-033) Medication Use Evaluation of Third Generation Cephalosporins in a Community Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(3-034) Staying Current with Beta (ß) Lactam Allergy Management: Updates and Visual Tools for Clinicians
Favorite
12:00 PM – 1:00 PM
(3-035) Four-Year Review of Summer Pipeline Program Aimed to Engage High School Students to Profession of Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-036) Identifying and Prioritizing Hospitalized Patients with a Beta-lactam Antibiotic Allergy Label (BAAL) and Unrevealed Tolerance for Non-invasive Delabeling Opportunities
Favorite
12:00 PM – 1:00 PM
(3-037) The Antimicrobial Prism—Designing an Antibiotic Spectrum Reference Tool for Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(3-038) Vancomycin Discontinuation After Negative MRSA Nasal Swab PCR Assay in the MICU/CCU
Favorite
12:00 PM – 1:00 PM
(3-039) A meta-analysis on the safety of prolonged vs standard infusion of beta-lactams
Favorite
12:00 PM – 1:00 PM
(3-040) Intravenous to Oral Metoprolol Versus Diltiazem for Rate Control in Acute Atrial Fibrillation in the Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-041) Small Cell Prostate Carcinoma – Rare Neuroendocrine Cell Differentiation in Prostate Cancer
Favorite
12:00 PM – 1:00 PM
(3-042) Neoadjuvant Chemotherapy for the Treatment of Myxoid Liposarcoma: AKA vs. Limb-Sparing Surgery
Favorite
12:00 PM – 1:00 PM
(3-043) Extended-release Naltrexone-Induced Injection Site Reaction
Favorite
12:00 PM – 1:00 PM
(3-044) Targeting Non-Immune Mediated Intolerances: Low-Hanging Fruit for Direct De-Labeling of Beta-Lactam Antibiotic Allergy Labels (BAAL)
Favorite
12:00 PM – 1:00 PM
(3-045) Retrospective Evaluation of Vancomycin Use in an Urban Safety Net Hospital
Favorite
12:00 PM – 1:00 PM
(3-046) Recommending Over the Counter Products to Pregnant Patients: What Do Practicing Pharmacists and Obstetrician-Gynecologist Clinicians Think?
Favorite
12:00 PM – 1:00 PM
(3-047) Cardiovascular Risk Among an Underserved Chinese American Community in Chicago: A Graduate Student Health Organization Prioritizing Community Health Needs
Favorite
12:00 PM – 1:00 PM
(3-048) Identification of Chemosensitizing Agents in Ovarian Cancer via High-throughput Screening of an FDA Drug Library
Favorite
12:00 PM – 1:00 PM
(3-049) Comparison of Student and Preceptor Evaluations on Advanced Pharmacy Practice Experiential Student Performance
Favorite
12:00 PM – 1:00 PM
(3-050) Burn Injury Patterns in Emergency Department Visits
Favorite
12:00 PM – 1:00 PM
(3-051) Emergency Department Visits for Alcohol-Related Incidents in the United States
Favorite
12:00 PM – 1:00 PM
(3-052) Obesity Patterns among Adolescents in the United States
Favorite
12:00 PM – 1:00 PM
(3-053) Illinois Council of Health-System Pharmacists Student Chapter Activities at Rosalind Franklin University
Favorite
12:00 PM – 1:00 PM
(3-054) Implementation of a Medication History Smart Phrase to Improve Quality of Documentation in an Interprofessional Student-Led Free Clinic
Favorite
12:00 PM – 1:00 PM
(3-055) Reducing Provider Alert Fatigue in a Hospital System: Turning Down the Noise and Pumping Up Patient Safety
Favorite
12:00 PM – 1:00 PM
(3-056) Glycemic Control in Hospitalized Patients Receiving Total Parenteral Nutrition
Favorite
12:00 PM – 1:00 PM
(3-057) Evaluation of Bruton’s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia Patients at a Community Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(3-058) Evaluation of Heparin Infusion Dose Adjustments Using Institutional Acute Coronary Syndrome and Medical Heparin Infusion Protocols
Favorite
12:00 PM – 1:00 PM
(3-059) Assessment of Kcentra Usage and Place in Therapy Among Pharmacists
Favorite
12:00 PM – 1:00 PM
(3-060) Vitamin D Level Screening and Supplementation During Hospital Stay
Favorite
12:00 PM – 1:00 PM
(3-061) Evaluation of Spironolactone and Furosemide in Hospitalized Patients with Cirrhosis and Ascites
Favorite
12:00 PM – 1:00 PM
(3-062) The Practicing Pharmacist’s Perspective: Alcohol Consumption and Access to Resources
Favorite
12:00 PM – 1:00 PM
(3-063) Assessing Alcohol Use in Pharmacy Students and Associated Factors
Favorite
12:00 PM – 1:00 PM
(3-064) Patterns in Pharmacy Student Mental Health Disorder Prevalence, Treatment, and Resource Utilization
Favorite
12:00 PM – 1:00 PM
(3-065) Assessing the Impact of Wellness Days in the School of Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-066) Review of a Pharmacy Curriculum with an Inclusive Language Lens
Favorite
12:00 PM – 1:00 PM
(3-067) Safety Evaluation of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in Patients with Breast Cancer at a Community Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(3-068) Surveying providers on the use of Single Maintenance and Reliver Therapy (SMART) for the treatment of asthma
Favorite
12:00 PM – 1:00 PM
(3-069) Urinary Incontinence and Behavioral Interventions
Favorite
12:00 PM – 1:00 PM
(3-070) Oral Cefdinir, a Low Bioavailable Antibiotic Compared to Alternative Oral Antibiotics for Gram Negative Bacteremia
Favorite
12:00 PM – 1:00 PM
(3-071) Post-Operative Opioid Analgesic Use in Thoracic Surgery Patients who underwent Cryo Nerve Block versus Patients who received PCA or Epidural
Favorite
12:00 PM – 1:00 PM
(3-072) Walk with a Doc
Favorite
12:00 PM – 1:00 PM
(3-073) Evaluation of Appropriate Screening and Administration of Tdap Vaccination in Adult Emergency Department
Favorite
12:00 PM – 1:00 PM
(3-074) Development of a REDCap-based Study Intake and Activation Checklist for an Investigational Drug Service
Favorite
12:00 PM – 1:00 PM
(3-075) Diltiazem in the treatment of atrial fibrillation/flutter with rapid ventricular rate (AFF RVR): Comparing calcium pre-treatment vs placebo in prevention of diltiazem induced hypotension.
Favorite
12:00 PM – 1:00 PM
(3-076) Extending Ophthalmic Medication Bottle BUDs from 28 days to Manufacturer Expiration Date
Favorite
12:00 PM – 1:00 PM
(3-077) Impact of the University of Illinois at Chicago College of Pharmacy’s Teaching Methods on Visiting International Students
Favorite
12:00 PM – 1:00 PM
(3-078) Impact of a Pediatric-Trained Clinical Pharmacist in Pediatric Outpatient Kidney Transplant Clinic
Favorite
12:00 PM – 1:00 PM
(3-079) Evaluating Preferences for Telemedicine versus In-Person Clinics among Underserved Asian American Populations
Favorite
12:00 PM – 1:00 PM
(3-080) Capturing the Convenience: Enhancing Medication Accessibility for Transplant Patients through Integrated Health-System Mail Order Pharmacy Approach
Favorite
12:00 PM – 1:00 PM
(3-081) Assessing the Value of Home Courier Service for Sterile Compounded Medications
Favorite
12:00 PM – 1:00 PM
(3-082) Standard operating procedure for internal transportation of investigational products
Favorite
12:00 PM – 1:00 PM
(3-083) Cultivating Clinical and Professional Skills in Pharmacy Interns Within a Health System Specialty Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-084) Assessing the Cost-Effective Benefits of Rounding Infusion Medication Dosages for Reduced Waste
Favorite
12:00 PM – 1:00 PM
(3-086) Tamsulosin-induced Priapism Resulting from Alpha Antagonism
Favorite
12:00 PM – 1:00 PM
(3-087) Engineering of living cells based on polyphenolic moieties from plant extractions for drug delivery.
Favorite
12:00 PM – 1:00 PM
(3-089) Outpatient Antibiotic Stewardship with a Focus on Upper Respiratory and Urinary Tract Infections
Favorite
12:00 PM – 1:00 PM
(3-090) Safety of Morphine in Patients with Cirrhosis
Favorite
12:00 PM – 1:00 PM
(3-091) Impact of formal opioid tolerance level assessment on postoperative pain in patients undergoing total joint arthroplasty.
Favorite
12:00 PM – 1:00 PM
(3-092) Enoxaparin Dosing in Class III Obesity for Venous Thromboembolism Prophylaxis
Favorite
12:00 PM – 1:00 PM
(3-093) "Flushing Intermittent IV Medications" Policy: Compliance and Compatability
Favorite
12:00 PM – 1:00 PM
(3-094) Smart Pump Auto-Programming Compliance with High-Alert Medications
Favorite
12:00 PM – 1:00 PM
(3-095) Analysis of Symptom-Triggered Alcohol Withdrawal Protocol at Veteran Health Indiana
Favorite
12:00 PM – 1:00 PM
(3-096) Incidence and Severity of Cardiac Dysfunction in Patients Receiving Trastuzumab Antibody Drug Conjugates
Favorite
12:00 PM – 1:00 PM
(3-097) Clinical and Revenue Monitoring After Implementation of Long-Acting Cabotegravir and Rilpivirine in an Urban Safety-Net Hospital HIV Clinic
Favorite
12:00 PM – 1:00 PM
(3-098) Cannabidiol and Anxiety in College-Aged Individuals
Favorite
12:00 PM – 1:00 PM
(3-099) Impact of EHR (Electronic Health Record) Modification on Acetazolamide Prescribing Practices in a Pediatric Hospital
Favorite
12:00 PM – 1:00 PM
(3-100) The rate of myocarditis adverse events in immune checkpoint inhibitors
Favorite
12:00 PM – 1:00 PM
(3-101) Evaluation of Intravenous Iron in the Inpatient Setting at a Large Health System
Favorite
12:00 PM – 1:00 PM
(3-102) Empowering Family Caregivers: Evaluating Community Pharmacists’ Roles in Medication Management for Older Adults and their Family Caregivers
Favorite
12:00 PM – 1:00 PM
(3-103) Evaluation of intravenous immunoglobulin utilization in pediatric and neonate population within a community health system
Favorite
12:00 PM – 1:00 PM
(3-104) Medication Use Evaluation of IL-17 and IL-23 Inhibitors at a Large Health System
Favorite
12:00 PM – 1:00 PM
(3-105) Medication Use Evaluation on Perioperative Buprenorphine-Naloxone and Methadone
Favorite
12:00 PM – 1:00 PM
(3-106) Evaluation of System-Wide Buprenorphine Prescribing, Follow-Up, and Readmissions
Favorite
12:00 PM – 1:00 PM
(3-107) Prevalence of ICU patients with risk of drug-induced QT prolongation in Saudi Arabia
Favorite
12:00 PM – 1:00 PM
(3-108) Assessment of the Pharmacy Daily Monitoring Task for Direct Oral Anticoagulant Drug Orders
Favorite
12:00 PM – 1:00 PM
(3-109) Pharmacist’s Role in the Management of Gestational Diabetes in an Obstetrics and Gynecology Clinic
Favorite
12:00 PM – 1:00 PM
(3-110) Outpatient Antibiotic Ordering in an Academic Health System: A Retrospective Multicenter Evaluation
Favorite
12:00 PM – 1:00 PM
(3-111) Medication Use Evaluation of Apixaban and Rivaroxaban Dosing Practices in Atrial Fibrillation at a Large, Single-Center Institution
Favorite
12:00 PM – 1:00 PM
(3-112) Evaluation of Treatment Outcomes Utilizing Beractant in Respiratory Distress Syndrome
Favorite
12:00 PM – 1:00 PM
(3-113) Current evidence and place-in-therapy of abiraterone and lutetium-177 vipivotide tetraxetan for the treatment of metastatic castration-resistant prostate cancer
Favorite
12:00 PM – 1:00 PM
(3-114) Evaluation of Prophylactic Antimicrobial Use in Open Chest Management in a Cardiac Care Center in London, England
Favorite
12:00 PM – 1:00 PM
(3-115) Evaluating the Efficacy of a Pharmacist and Nurse-Led Heart Failure Clinic in Optimizing Guideline-Directed Medical Therapy (GDMT) in Comparison to General Cardiology Outpatient Offices.
Favorite
12:00 PM – 1:00 PM
(3-116) Outpatient Antibiotic Prescribing within a Regional Health System: A Retrospective, Multicenter Evaluation
Favorite
12:00 PM – 1:00 PM
(3-117) Evaluation of nitroglycerin prescribing at discharge in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI)
Favorite
12:00 PM – 1:00 PM
(3-118) Filling the Prescription for Equality: LGBTQ+ Resources in National and State Pharmacy Organizations
Favorite
12:00 PM – 1:00 PM
(3-119) Evaluation of Pharmacist-Prescribed Nirmatrelvir/ritonavir Compared to a Referral Center Approach for Outpatient Covid-19 Therapies in a Community Health System
Favorite
12:00 PM – 1:00 PM
(3-120) Potential Impact of Preemptive Pharmacogenomic Genotyping in Children and Young Adults Diagnosed with Leukemia
Favorite
12:00 PM – 1:00 PM
(3-121) Evaluation of Extravasation Management Policy and Protocol
Favorite
12:00 PM – 1:00 PM
(3-122) Direct Oral Anticoagulants Dosage Evaluation
Favorite
12:00 PM – 1:00 PM
(3-123) Community Health Center Patient and Provider Perspectives of the Helping Build Healthy Communities Initiative: A Qualitative Study
Favorite
12:00 PM – 1:00 PM
(3-124) Impact of Outpatient Antibiotics and Antibiotic Susceptibility in Pediatric Cystic Fibrosis
Favorite
12:00 PM – 1:00 PM
(3-125) Should You Weight? Does First Dose Therapeutic Drug Monitoring Predict Steady State Pharmacokinetics of Vancomycin in Patients with Morbid Obesity?
Favorite
12:00 PM – 1:00 PM
(3-126) Evaluation of a Cardiology Ambulatory Care Pharmacist-Led Service on Adherence to Antiarrhythmic Drug Monitoring
Favorite
12:00 PM – 1:00 PM
(3-127) Enhancing Community Pharmacists’ Role in Research: Insights and Challenges in Recruiting through Pharmacy Practice-Based Research Networks (PBRNs)
Favorite
12:00 PM – 1:00 PM
(3-128) Medication Use Evaluation of Tenecteplase versus Alteplase for Acute Ischemic Stroke: Door-to-Needle Time and Safety Outcomes
Favorite
12:00 PM – 1:00 PM
(3-129) Utilization of Conflict Style Evaluations by Student Pharmacists participating in International Advanced Pharmacy Practice Experiences (APPE) in Kenya
Favorite
12:00 PM – 1:00 PM
(3-130) The Impact of Daily Pillbox Use on Patient Medication Adherence
Favorite
12:00 PM – 1:00 PM
(3-131) Assessment of Patient Eligibility for Ethyl Eicosapentaenoic Acid Therapy in a Post-Myocardial Infarction Cardiac Care Clinic in London, England
Favorite
12:00 PM – 1:00 PM
(3-132) Assessment of Diuretic Prescribing Patterns Following Cardiac Surgery at a Cardiac Care Center in London, England
Favorite
12:00 PM – 1:00 PM
(3-133) A Study on the Satisfaction of Patients with Rheumatoid Arthritis for Tele-pharmaceutical Care Service : A Randomized Controlled Pilot Trial
Favorite
12:00 PM – 1:00 PM
(3-134) Comparative Study to Evaluate the Effectiveness of Using Closed System Drug Transfer Devices (CSTD) in South Korea
Favorite
12:00 PM – 1:00 PM
(3-135) Analysis of nutrition support in the surgical intensive care unit
Favorite
12:00 PM – 1:00 PM
(3-136) Incidence And Prevalence Of IV Medication Errors
Favorite
12:00 PM – 1:00 PM
(3-137) Patients' Level of Knowledge of Drug-Drug Interactions in Saudi Arabia: A Cross-Sectional Study
Favorite
12:00 PM – 1:00 PM
(3-138) Inflammation and Treatment-Resistant Depression from Clinical to Animal Study: A Possible Link?
Favorite
12:00 PM – 1:00 PM
(3-139) Influence of premedication with dexamethasone and pertuzumab combination on infusion reactions during trastuzumab therapy in patients with breast cancer
Favorite
12:00 PM – 1:00 PM
(3-140) Impacts of Board-spectrum Carbapanem Durations and Early De-escalation to ICU Outcomes in A Medical Center in Taiwan– A Retrospective, Cohort Study
Favorite
12:00 PM – 1:00 PM
(3-142) Hospitalizations for exacerbations or acute respiratory infections in older patients with chronic inflammatory airway disease: Incidence and Risk factors
Favorite
12:00 PM – 1:00 PM
(3-143) Assessing Medication History Discrepancies: A Comparative Study of Sources and Factors Impacting Medication Discrepancies
Favorite
12:00 PM – 1:00 PM
(3-144) Using Personal Health Records for Medication Continuity during Transition of Care: An Observational Study
Favorite
12:00 PM – 1:00 PM
(3-145) Evaluation of excessive INR elevation during warfarin therapy in anticoagulation service
Favorite
12:00 PM – 1:00 PM
(3-146) Evaluation of Intramuscular Penicillin Use and Treatment Outcomes in Neonatal Patients
Favorite
12:00 PM – 1:00 PM
(3-147) Analysis of the As-Needed Antihypertensive Agent Use per Dose for Asymptomatic Hypertension within a Metropolitan Health System
Favorite
12:00 PM – 1:00 PM
(3-148) Collaborative Development and Evaluation of a Pediatric Vaccine Toolkit by Pharmacists, Nurses, and Child Life Specialists
Favorite
12:00 PM – 1:00 PM
(3-149) Pharmacist and Student Pharmacist Perceptions of Barriers and Opportunities for Patient-Centered Care in Substance Use Disorders
Favorite
12:00 PM – 1:00 PM
(3-150) Oral Thyroid Hormone Supplementation for Hair Growth in a Euthyroid Patient: An Inappropriate Indication
Favorite
12:00 PM – 1:00 PM
(3-151) Evaluation of Intravenous Iron Replacement in Patients with Iron Deficiency and Acute Decompensated Heart Failure
Favorite
12:00 PM – 1:00 PM
(3-152) Evaluation of Specialty Pharmacy Turnaround Time for Migraine Prophylaxis after Implementation of Therapeutic Interchange
Favorite
12:00 PM – 1:00 PM
(3-153) Therapeutic Enoxaparin Dosing in the Inpatient Obese Population
Favorite
12:00 PM – 1:00 PM
(3-154) Evaluation of Hypertension, Diabetes Mellitus, and Hyperlipidemia Management in Heart Transplant Patients at One-Year Post Transplant
Favorite
12:00 PM – 1:00 PM
(3-155) Assessment of Time to Therapeutic INR in Lung Transplant Recipients Initiated on Warfarin
Favorite
12:00 PM – 1:00 PM
(3-156) Assessment of the Prevalence of Hypocalcemia in Trauma Patients Receiving Blood Products
Favorite
12:00 PM – 1:00 PM
(3-157) Reflections in the Rear View: Professional Identity Formation among PGY2 PMPC Residency Graduates
Favorite
12:00 PM – 1:00 PM
(3-158) Inpatient Use of Sodium-Glucose Cotransporter-2 Inhibitors
Favorite
12:00 PM – 1:00 PM
(3-159) Improving Operational Efficiencies and Patient Satisfaction Through Implementation of Unilateral Text Messaging in a Health-System Specialty Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-160) Screening for a Preclinical Alzheimer's Disease Study: A Clinical Trial Site Experience
Favorite
12:00 PM – 1:00 PM
(3-161) Availability of Blood Glucose Monitors in Community Pharmacies
Favorite
12:00 PM – 1:00 PM
(3-162) Pilot Analysis of Pharmacists’ Thought Process During Therapeutic Drug Monitoring of Vancomycin and Associated Trough Orders to Design Optimized Alerts in Electronic Health Records
Favorite
12:00 PM – 1:00 PM
(3-163) Comparing Immunotherapy and Targeted Therapy in Patients with BRAF Mutant Cancers
Favorite
12:00 PM – 1:00 PM
(3-164) Assessment of Discharge Medications Following Therapeutic Interchange of Frequently Exchanged Drug Classes
Favorite
12:00 PM – 1:00 PM
(3-165) Evaluation of Pharmacist Managed Type 2 Diabetes Mellitus in the Primary Care Setting
Favorite
12:00 PM – 1:00 PM
(3-166) Factors Impacting Professional Identity Formation in First-Year Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(3-167) Assessing the Impact of Prescribing Restrictions on Utilization of Intravenous Immunoglobulin (IVIG) use at at a Pediatric Hospital System
Favorite
12:00 PM – 1:00 PM
(3-168) Evaluating the Implementation of a Silent Best Practice Alert and Patient Outreach Initiative to Improve Blood Pressure Control in the Ambulatory Setting
Favorite
12:00 PM – 1:00 PM
(3-170) Intrapleural Alteplase and Dornase Alpha Medication Use Evaluation
Favorite
12:00 PM – 1:00 PM
(3-171) Development of a Pharmacy School Orientation Module for First Professional-Year Student Pharmacists
Favorite
12:00 PM – 1:00 PM
(3-172) Pharmacodynamics of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa in an in vitro cystic fibrosis sputum biofilm model
Favorite
12:00 PM – 1:00 PM
(3-173) Words Matter: Impact of Microbiology Laboratory Result Presentation on Antibiotic Stewardship
Favorite
12:00 PM – 1:00 PM
(3-174) Establishment of Locally Validated Methicillin Resistant Staphylococcus Aureus Risk Factors
Favorite
12:00 PM – 1:00 PM
(3-175) Influence of Time to Administration of Angiotensin II on Clinical Outcomes Following Vasoplegic Shock
Favorite
12:00 PM – 1:00 PM
(3-176) Comparison of Camper Satisfaction Scores for a 1-Day vs. 2-Day Camp at the University of Kansas Pharmacy Summer Camp
Favorite
12:00 PM – 1:00 PM
(3-177) Assessment of Professional Year Three Pharmacy Students’ Performance in a Journal Club Milestone to Improve Curriculum Design
Favorite
12:00 PM – 1:00 PM
(3-178) Evaluation and Assessment of Propofol Use in an Emergency Department Setting for Moderate Sedation Procedures
Favorite
12:00 PM – 1:00 PM
(3-179) Medication Use Evaluation Regarding Appropriate Utilization of Oral and Intravenous Levofloxacin in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-180) Impact of Propofol on Triglycerides in Intubated ICU Patients
Favorite
12:00 PM – 1:00 PM
(3-181) Evaluation of Time to Angiotensin II Administration on Responsiveness In Septic Shock
Favorite
12:00 PM – 1:00 PM
(3-182) PTEN and Gynecologic Cancers: An Outcomes Assessment
Favorite
12:00 PM – 1:00 PM
(3-183) Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: An Analysis of Electronic Health Record Data
Favorite
12:00 PM – 1:00 PM
(3-184) Use of Antibiotics with Anaerobic Coverage in Acute Myeloid Leukemia Patients Who Received High-intensity Chemotherapy
Favorite
12:00 PM – 1:00 PM
(3-186) Managing High Demands for GLP-1 RA: A Pharmacists Role
Favorite
12:00 PM – 1:00 PM
(3-187) Evaluation of a Pharmacy-Driven Enoxaparin Protocol in Obese Patients
Favorite
12:00 PM – 1:00 PM
(3-188) Outpatient Antibiotic Prescribing Rates during the COVID-19 Pandemic
Favorite
12:00 PM – 1:00 PM
(3-189) Navigating Mycobacterium Abcessus: A Complex Case Report
Favorite
12:00 PM – 1:00 PM
(3-190) Comparison of Time to Treatment Initiation of Specialty Medications Between an Integrated Health System Specialty Pharmacy and External Specialty Pharmacies
Favorite
12:00 PM – 1:00 PM
(3-191) Comparison of GLP-1 Receptor Agonist Prior Authorization Approvals and Denials by Medication Indication: A Retrospective Cohort Study
Favorite
12:00 PM – 1:00 PM
(3-192) Characterization of Antimicrobial Prophylactic Practices in United States Emergency Departments: A Multicenter Survey of Institutional and Pharmacy Practices
Favorite
12:00 PM – 1:00 PM
(3-193) Assessing the Readability of Pulmonary Hypertension Drug Product Patient Package Inserts
Favorite
12:00 PM – 1:00 PM
(3-195) Simulation Based Education (SBE) in pharmacy technicians: a consensus study
Favorite
12:00 PM – 1:00 PM
(3-196) Navigating Xylazine Adulteration: A Pediatric Case of Opioid Overdose and High-Dose Naloxone
Favorite
12:00 PM – 1:00 PM
(3-197) Impact of a Urine Culture Order Set at a Single Veterans Affairs Institution
Favorite
12:00 PM – 1:00 PM
(3-198) County-Level Variation in Buprenorphine Dispensing in Appalachian Kentucky: A Descriptive Study
Favorite
12:00 PM – 1:00 PM
(3-199) A Retrospective Medication Use Evaluation Regarding a Community Based Hospital’s Heparin Protocols
Favorite
12:00 PM – 1:00 PM
(3-200) Going with the Flozin: A Medication Use Evaluation for Inpatient Use of SGLT-2 Inhibitors
Favorite
12:00 PM – 1:00 PM
(3-201) Case Report: Splenic Rupture Secondary to Epstein-Barr Virus
Favorite
12:00 PM – 1:00 PM
(3-202) Impact of Prior Authorization Denial and Appeals Process on Time to Treatment in an Ambulatory Infusion Setting
Favorite
12:00 PM – 1:00 PM
(3-203) Medications and Topics that are Discussed the Most Within the Alpha-gal Community
Favorite
12:00 PM – 1:00 PM
(3-204) Impact of Dual Targeted Therapy on Outcomes in Patients with Inflammatory Bowel Disease
Favorite
12:00 PM – 1:00 PM
(3-205) Recurrent Disseminated Gonococcal Infection (DGI) in a Patient with Indwelling Wrist Hardware
Favorite
12:00 PM – 1:00 PM
(3-206) Barriers to Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction at Hospital Discharge
Favorite
12:00 PM – 1:00 PM
(3-207) Impact of a Clinical Pharmacist Initiative on Osteoporosis Management in Women Who Had a Fracture (OMW)
Favorite
12:00 PM – 1:00 PM
(3-208) Retrospective Medication Use Evaluation at a Community-Based Hospital’s Perioperative Antibiotic Utilization
Favorite
12:00 PM – 1:00 PM
(3-209) Evaluation of Aminoglycoside Utilization at a Large Academic Medical Center in Southeastern Louisiana
Favorite
12:00 PM – 1:00 PM
(3-210) Appropriateness of IV Iron Use in Outpatients with Heart Failure
Favorite
12:00 PM – 1:00 PM
(3-211) Evaluation of Student Engagement in an Online Interprofessional Education (IPE) Event
Favorite
12:00 PM – 1:00 PM
(3-212) Critical Care Concepts: Do we and do we need to be teaching them in the Doctor of Pharmacy Curriculum
Favorite
12:00 PM – 1:00 PM
(3-213) The Effectiveness of Supplemental Instruction (SI) at University of Louisiana Monroe College of Pharmacy
Favorite
12:00 PM – 1:00 PM
(3-214) Hyponatremia associated with the use of niraparib, a poly ADP-ribose polymerase (PARP) enzyme inhibitor
Favorite
12:00 PM – 1:00 PM
(3-215) Evaluation of Hypoglycemic Events in Hyperosmolar Hyperglycemic Syndrome
Favorite
12:00 PM – 1:00 PM
(3-216) Assessing Health Needs in a Dominican Republic Community During an Interprofessional Service-Learning Trip
Favorite
12:00 PM – 1:00 PM
(3-217) Assessing Probability of Medication-related Falls for Inpatients
Favorite
12:00 PM – 1:00 PM
(3-218) Etomidate versus Ketamine for Rapid Sequence Intubation in Patients with Obesity
Favorite
12:00 PM – 1:00 PM
(3-219) Health Disparity in the First-Line Treatment Used for Work-Age Breast Cancer Survivors with Early Stage HER2+ and HER2- Breast Cancer in Louisiana
Favorite
12:00 PM – 1:00 PM
(3-220) Risk assessment of vancomycin, daptomycin, and linezolid associated adverse effects in managing methicillin resistant staphylococcus aureus confirmed bacteremia in African American patients
Favorite
12:00 PM – 1:00 PM
(3-221) Impact of a MRSA Decolonization Protocol on Resistant Gram-Positive Infections in Neonatal and Cardiac Intensive Care Units
Favorite
12:00 PM – 1:00 PM
(3-222) Assessing proficiency and perspectives of the COVID-19 virus among healthcare professionals and faith-based wellness leaders
Favorite
12:00 PM – 1:00 PM
(3-223) Identifying Courses/Trainings for Healthcare Students and Providers on Cultural Issues that Address Men and Women’s Needs Across a Lifespan
Favorite
12:00 PM – 1:00 PM
(3-224) Decreasing the Stigma against HIV/AIDS through State Laws
Favorite
12:00 PM – 1:00 PM
(3-225) Centrally Acting Maintenance Medications Interfering with Academic Success in Graduate Students
Favorite
12:00 PM – 1:00 PM
(3-226) Investigation of the Anticoagulant Activity of Cyclic Sulfated Glycosaminoglycan Mimetics
Favorite
12:00 PM – 1:00 PM
(3-227) Assessing Prescribing Patterns of Glucagon Like Peptide-1 Receptor Agonists (GLP-1 RAs) Amongst Different Racial/Ethnic Groups
Favorite
12:00 PM – 1:00 PM
(3-228) Assessing Prescribing Patterns of Guideline Directed Medical Therapy Amongst Minority Populations with Heart Failure
Favorite
12:00 PM – 1:00 PM
(3-229) Incidence of Lactic Acidosis with Postoperative Hyperglycemia in Pediatric Cardiothoracic Surgery Patients
Favorite
12:00 PM – 1:00 PM
(3-230) Inhibition of Alpha-glucosidase by Grapefruit Through an Antidiabetic Mechanism of Action
Favorite
12:00 PM – 1:00 PM
(3-231) Evaluation of Buprenorphine-Naloxone Continuity of Care and Hospital Readmission
Favorite
12:00 PM – 1:00 PM
(3-232) Retrospective Chart Review of the Incidence of Patients Discharged on Both an Antihypertensive Agent and Midodrine Initiated in the Intensive Care Unit
Favorite
12:00 PM – 1:00 PM
(3-233) Evaluation of a No Bolus Heparin Drip Protocol vs Standard Bolus Heparin Protocol in the Treatment of VTE
Favorite
12:00 PM – 1:00 PM
(3-234) Obstacles in Electronic Prescribing of Controlled Substances especially Opioids
Favorite
12:00 PM – 1:00 PM
(3-235) Insight into Pharmacy Students’ Perspectives on Mandatory Covid-19 Vaccines in Schools and Health Care Settings
Favorite
12:00 PM – 1:00 PM
(3-236) A Retrospective Evaluation of Primary Indication of Intravenous Levothyroxine
Favorite
12:00 PM – 1:00 PM
(3-237) Direct Oral Anticoagulants With or Without Antiplatelet Agents Versus Antiplatelet Agents Alone in Patients With Lower Extremity Peripheral Arterial Disease Following Revascularization
Favorite
12:00 PM – 1:00 PM
(3-238) Botulinum Toxin in the Treatment of Severe Acute Trismus
Favorite
12:00 PM – 1:00 PM
(3-239) Direct Oral Anticoagulants versus Warfarin in Patients with Isolated Heparin-induced Thrombocytopenia or Heparin-induced Thrombocytopenia with Thrombosis
Favorite
12:00 PM – 1:00 PM
(3-240) Vancomycin Induced Thrombocytopenia
Favorite
12:00 PM – 1:00 PM
(3-241) The Impact of COVID-19 testing Behaviors on COVID-19 Vaccine Uptake; A Longitudinal Cohort Study in Southeastern Louisiana
Favorite
12:00 PM – 1:00 PM
(3-242) Evaluation of the Association between Sickle Cell Disease and Breast Cancer using the All of Us Research Program Dataset (AoURP)
Favorite
12:00 PM – 1:00 PM
(3-243) Perception of the COVID-19 Pandemic and Its Impact on the Mental Health of Second Year Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(3-244) Safety of Treating Pediatric Diabetic Ketoacidosis in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(3-245) Transforming Type 2 Diabetes Management: Optimizing Time in Range with the Use of a Continuous Glucose Monitor
Favorite
12:00 PM – 1:00 PM
(3-246) Effectiveness of implementing a prescribing card at an express care center to increase appropriateness of first-line antibiotic therapy for uncomplicated urinary tract infection
Favorite
12:00 PM – 1:00 PM
(3-247) Frequency of Adverse Drug Events Due to Unexpected Reactions from Biologics Used for Crohn’s Disease
Favorite
12:00 PM – 1:00 PM
(3-248) Comparison of Bivalirudin to Heparin in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)
Favorite
12:00 PM – 1:00 PM
(3-249) Drug Design and Discovery of N-aryl Enaminones for the Treatment of Generalized Drug-resistant Epilepsy
Favorite
12:00 PM – 1:00 PM
(3-250) Prevalence of Mortality Benefit Beta Blockers Prescribed at Discharge Following Myocardial Infarction in Patients with Heart Failure with Reduced Ejection Fraction
Favorite
12:00 PM – 1:00 PM
(3-251) Evaluating the Stability of Antiretroviral Agents in Adherence-prompting Packaging
Favorite
12:00 PM – 1:00 PM
(3-252) Prevalent Use of Over-the-Counter Products in Various Guidelines for Managing Pain in Different Disease States
Favorite
12:00 PM – 1:00 PM
(3-253) Pharmacist-Provided Telehealth Services and Outcomes in the United States: A Scoping Review
Favorite
12:00 PM – 1:00 PM
(3-254) Assessing Patient Spirituality and Perspectives on Pharmacists Inquiring about Spiritual Needs in Community Care Settings
Favorite
12:00 PM – 1:00 PM
(3-255) Assessment of Sexual Health Education in US Pharmacy Schools Curricula
Favorite
12:00 PM – 1:00 PM
(3-256) Evaluation of anaerobic antimicrobials in pediatric patients
Favorite
12:00 PM – 1:00 PM
(3-257) Impact of Send-Out Anaerobic Cultures on Antibiotic Prescribing Practices
Favorite
12:00 PM – 1:00 PM
(3-258) Interdisciplinary Approach to Review and Address Hypoglycemia Events at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-259) Targeted Outreach to Increase Preventative Healthcare Education at Title 1 Baltimore City Elementary Schools
Favorite
12:00 PM – 1:00 PM
(3-260) Effect of Journal Impact Factor on Women Pharmacist Representation in Critical Care Scholarship
Favorite
12:00 PM – 1:00 PM
(3-261) Impact of a Clinical Pharmacist-Led Comprehensive Diabetes Management Program on Diabetes Outcomes at a Federally Qualified Health Center
Favorite
12:00 PM – 1:00 PM
(3-262) Community Pharmacists’ Perspectives on their Role in Improving Clinical Trial Diversity
Favorite
12:00 PM – 1:00 PM
(3-263) Retrospectively Reviewing the Use of Clindamycin for Skin and Soft Tissue Infections in the University of Maryland Children's Hospital
Favorite
12:00 PM – 1:00 PM
(3-264) Management of Heart Failure in University Family Medicine Clinic Patients
Favorite
12:00 PM – 1:00 PM
(3-265) Decreasing the Burdens of Dropping the A1c: The Role of Health-Related Social Needs and Continuous Glucose Monitoring in Glycemic Control
Favorite
12:00 PM – 1:00 PM
(3-266) Assessing Adherence to IV Iron Therapy Recommendations in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency Anemia
Favorite
12:00 PM – 1:00 PM
(3-267) Successful Implementation and Improved A1C with a Bolus Only Insulin Patch Using Regular 500 unit/milliliter Insulin
Favorite
12:00 PM – 1:00 PM
(3-268) ALDH2 Deficiency and Nitroglycerin (NTG) Efficacy: Focus on Asian American Acute Angina Patients
Favorite
12:00 PM – 1:00 PM
(3-269) Treatment and Management of a Level 3 Hypoglycemic Reaction at a Primary Care Pharmacy Visit
Favorite
12:00 PM – 1:00 PM
(3-270) Tolerability of Concurrent Use of an Opioid and Low-dose Naltrexone in Chronic Pain Management
Favorite
12:00 PM – 1:00 PM
(3-271) Assessment of Antimicrobial Stewardship Protocol Compliance and De-prescribing Trends at a Tertiary Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-272) Potential drug interactions of direct oral anticoagulants with anticancer drugs in hospitalized patients
Favorite
12:00 PM – 1:00 PM
(3-273) Clinical management of Steroid-induced Hyperglycemia in an outpatient setting: A case report
Favorite
12:00 PM – 1:00 PM
(3-274) Pharmacogenomic implications for succinylcholine use in a patient homozygous for the K variant of the BCHE gene
Favorite
12:00 PM – 1:00 PM
(3-275) Cell Penetrating Peptides for Improved Intracellular Drug Delivery to Non-Small Cell Lung Cancer (NSCLC)
Favorite
12:00 PM – 1:00 PM
(3-276) An Evaluation of Nanoparticles used to Enhance Drug Uptake by Pancreatic Tumor Cells
Favorite
12:00 PM – 1:00 PM
(3-277) An Evaluation of Specialized Nanoparticles for Enhanced Targeting and Treatment of Triple-Negative Breast Cancer
Favorite
12:00 PM – 1:00 PM
(3-278) Comparison of Medication Guidance between ChatGPT and Medication Leaflets for Glucagon-like peptide-1 and Dual Gastric Inhibitory Peptide and Glucagon-like Peptide-1 Receptor Agonists
Favorite
12:00 PM – 1:00 PM
(3-279) Treating Thrombocytopenia, Hyperglycemia, Splenic Vein Thrombosis, and Necrotizing Pancreatitis: A Case Report
Favorite
12:00 PM – 1:00 PM
(3-280) Evolocumab in Statin-Intolerant Patient
Favorite
12:00 PM – 1:00 PM
(3-281) Role of Imatinib Mesylate in Improving Outcomes of Pediatric Pulmonary Vein Stenosis (PVS)
Favorite
12:00 PM – 1:00 PM
(3-282) Investigating the Efficacy and Safety of a Topical Vaginal Delivery Method in Patients with Chronic Pelvic Pain
Favorite
12:00 PM – 1:00 PM
(3-283) Protracted Opioid Withdrawal After Tapering Long-Term Opioid Therapy: a Case Series
Favorite
12:00 PM – 1:00 PM
(3-284) Correlation of BPSD and Angiotensin II Receptor Modulating Antihypertensives
Favorite
12:00 PM – 1:00 PM
(3-285) Plant-Based Drug Testing Assays: Advancing Ethical Alternatives
Favorite
12:00 PM – 1:00 PM
(3-286) Prolonged Adverse Effects of Dextroamphetamine-Amphetamine with Concurrent use of Semaglutide
Favorite
12:00 PM – 1:00 PM
(3-287) Understanding Adolescent Substance Use Disorder and Current Strategies to Address the Issue
Favorite
12:00 PM – 1:00 PM
(3-288) Assessing the Rates of Co-Prescribed Serotonergic Agents In Patients Prescribed Opioids and Benzodiazepines Daily: A Retrospective Study
Favorite
12:00 PM – 1:00 PM
(3-289) Influence of Intravenous Lipid Emulsion Oil Source on the Compatibility of Total Nutrient Admixtures with Commonly Used Intravenous Medications
Favorite
12:00 PM – 1:00 PM
(3-290) A Review of Strategies to Enhance Information Display of Drug-Drug Interactions for Patients
Favorite
12:00 PM – 1:00 PM
(3-291) Evaluation of the Evolving Treatment Landscape for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Favorite
12:00 PM – 1:00 PM
(3-292) Smart Inhaler Devices in the U.S. Market for Treatment of Asthma
Favorite
12:00 PM – 1:00 PM
(3-293) Effect of Bedtime Dosing of Antihypertensive Medication on Cardiovascular Outcomes: A Bayesian Meta-Analysis of Prospective Randomized Control Trials
Favorite
12:00 PM – 1:00 PM
(3-294) Treating Acute Promyelocytic Leukemia (APL) and infected hematoma in the setting of differentiation syndrome and multidrug-resistant infection
Favorite
12:00 PM – 1:00 PM
(3-295) Anti-inflammatory, Immunomodulatory, and Cardiovascular Disease Prevention Effects of Statin in People Living With HIV: A Systematic Review
Favorite
12:00 PM – 1:00 PM
(3-296) Metabolic, Intestinal, and Cardiovascular Benefits of Sotagliflozin in Patients with/without Type 2 Diabetes
Favorite
12:00 PM – 1:00 PM
(3-297) Mitigating the Impacts of Temperature Excursions on Medication Stability within A Hospital Setting
Favorite
12:00 PM – 1:00 PM
(3-298) Xylopia Aethiopica Extract as a potential antiproliferative agent in triple-negative breast cancer cells.
Favorite
12:00 PM – 1:00 PM
(3-299) Collaborative Transitions of Care in Latent Autoimmune Diabetes in Adults (LADA): A Case Report Highlighting the Role of Pharmacists
Favorite
12:00 PM – 1:00 PM
(3-300) Retrospective Evaluation of Sedation and Shivering Management in Targeted Temperature Management (TTM) for Post-Cardiac Arrest Care at a Community Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(3-301) Self-reflection Assessment for Improved Communication in First Year Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(3-302) The Treatment of "Diabesity" a Case Study
Favorite
12:00 PM – 1:00 PM
(3-303) A case of highly significant improvement in glycemic control and weight loss switching from semaglutide to tirzepatide
Favorite
12:00 PM – 1:00 PM
(3-304) Treatment Effects with GLP-1 Agonists in Persons with Diabetes at High Risk for Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials
Favorite
12:00 PM – 1:00 PM
(3-305) Appraisal of Cost-Free Heart Failure Applications Available for Patient Self-Monitoring.
Favorite
12:00 PM – 1:00 PM
(3-306) Ticagrelor Induced Shortness of Breath
Favorite
12:00 PM – 1:00 PM
(3-307) Comparative Analysis: Assessing Disparities in Racial Composition Between Clinical Site Databases and Actual Enrolled Participants
Favorite
12:00 PM – 1:00 PM
(3-308) Exploring Potential Benefit of CGM in Uncontrolled Type 2 Diabetes patients: A Case Report
Favorite
12:00 PM – 1:00 PM
(3-309) Unmasking the Connection: A Review of Meta-Analyses that Examine the Link Between COVID-19 Infection and Diabetes
Favorite
12:00 PM – 1:00 PM
(3-310) Cellular Targeted Nanoparticles to Enhance Cellular Uptake in Glioblastoma Multiforme
Favorite
12:00 PM – 1:00 PM
(3-311) Synthesis and structural activity relationship of new antimalarial drugs in the age of resistance.
Favorite
12:00 PM – 1:00 PM
(3-312) Retrospective Evaluation of Gastroparesis with Semaglutide Use
Favorite
12:00 PM – 1:00 PM
(3-313) Advancements in the Development of Novel Compounds for Chagas Disease Treatment
Favorite
12:00 PM – 1:00 PM
(3-314) Analysis of the naturally occurring psilocybin effects in patients with major depressive disorder and/or anxiety
Favorite
12:00 PM – 1:00 PM
(3-315) Semaglutide as a Potential Treatment for Binge Eating Disorder in a Patient with Class 1 Obesity: A Case Report
Favorite
12:00 PM – 1:00 PM
(3-316) Cyclin-Dependent Kinase 4 and 6 Inhibition Potentiates a Memory Skewing of Lymphocytes in Breast Cancer Patients and Murine Melanoma Models
Favorite
12:00 PM – 1:00 PM
(3-317) Evaluation of risk factors for hypoglycemia in critically ill patients
Favorite
12:00 PM – 1:00 PM
(3-318) Treatment Options for Prodromal Schizophrenia
Favorite
12:00 PM – 1:00 PM
(3-319) Evaluation of Dispensing Take-home Naloxone in an Academic Psychiatric Hospital
Favorite
12:00 PM – 1:00 PM
(3-320) Relationship between hemolysis and potassium levels
Favorite
12:00 PM – 1:00 PM
(3-321) Efficacy and Safety of Non-Antibiotic Alternatives for the Prophylaxis of Recurrent Urinary Tract Infections in Peri-/Post-menopausal Women.
Favorite
12:00 PM – 1:00 PM
(3-322) Retatrutide VS Mounjaro
Favorite
12:00 PM – 1:00 PM
(3-323) Evaluation of Broad-Spectrum Cannabidiol Treatment Within Hospital Formularies: Addressing Barriers and Establishing Clinical Protocols.
Favorite
12:00 PM – 1:00 PM
(3-324) Impact of antipsychotic or clonidine administration on time to incident ICU delirium resolution
Favorite
12:00 PM – 1:00 PM
(3-325) Women’s Health Literacy Among Northeastern University Students: Examining Reproductive Education and Abortion Access
Favorite
12:00 PM – 1:00 PM
(3-326) Improving Adherence to a Pre-Authorization Protocol at a Community Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-327) Evaluation of Patient Characteristics and Patient-Physician Interaction Scores in Older Adults with Atrial Fibrillation (AF): The SAGE-AF study
Favorite
12:00 PM – 1:00 PM
(3-328) Impact of Formulary Decision and Electronic Medical Record (EMR) Enhancements on Intravenous Acetaminophen Use
Favorite
12:00 PM – 1:00 PM
(3-329) Use of azithromycin for gastric motility in a patient with gastroparesis
Favorite
12:00 PM – 1:00 PM
(3-330) Evaluation of Luspatercept Dosing in Patients with Myelodysplastic Syndromes
Favorite
12:00 PM – 1:00 PM
(3-331) Retrospective Review of Ferric Carboxymaltose Induced Hypophosphatemia
Favorite
12:00 PM – 1:00 PM
(3-332) Applicability of Home Health Monitoring Tools for Detection of Delirium in Dementia
Favorite
12:00 PM – 1:00 PM
(3-333) Changes in Oncology Clinical Trial Complexity as Measured by a Scoring Tool for Investigational Drug Services at Massachusetts General Hospital (MGH) from 2016 to 2021
Favorite
12:00 PM – 1:00 PM
(3-334) Evaluation of an IV Push Cardiac Medication Guideline at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-335) Evaluation of a restricted approval process for intravenous acyclovir at an academic medical center
Favorite
12:00 PM – 1:00 PM
(3-336) Use of Psilocybin as a Natural Approach to Bipolar Disorder Treatment: A Literature Review
Favorite
12:00 PM – 1:00 PM
(3-337) More Time, Less Waste: The Impact of Mobile Dispense Tracking for Hand-Delivered Medications on Pharmacy Workload at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-338) Overlooked Cause of Hyperglycemia in End-Stage Renal Disease: A Case of Polypharmacy
Favorite
12:00 PM – 1:00 PM
(3-339) Aspirin De-escalation in Patients with Stable Coronary Artery Disease and Atrial Fibrillation on a Direct Oral Anticoagulant: a Retrospective Review
Favorite
12:00 PM – 1:00 PM
(3-340) Evaluation of the effect of kava supplement use on the amphetamine urine toxicology immunoassay in a 72-year-old male
Favorite
12:00 PM – 1:00 PM
(3-341) Analysis of Antiepileptic Drug Switching from Brand to Generic
Favorite
12:00 PM – 1:00 PM
(3-342) Improvement in Continuous Glucose Monitor Time in Range Targets in Patients switched from Glucagon-like Peptide-1 Receptor Agonist to Tirzepatide Therapy
Favorite
12:00 PM – 1:00 PM
(3-343) Patient knowledge and perceptions of insulin biologics and biosimilars
Favorite
12:00 PM – 1:00 PM
(3-344) Evaluation of inpatient utilization of continuous albuterol for reactive airway disease at a pediatric hospital
Favorite
12:00 PM – 1:00 PM
(3-345) Analysis of Pharmacist Interventions on Prophylactic Enoxaparin to Support Proposal of an Automatic Dosing Policy
Favorite
12:00 PM – 1:00 PM
(3-346) Impact of Mental Health Education in the Golden Bear Summer Camp
Favorite
12:00 PM – 1:00 PM
(3-347) Long-Term Effect of Pharmacist-Led Diabetes Distress Interventions on Glucose Management and Weight Among People with Type 2 Diabetes
Favorite
12:00 PM – 1:00 PM
(3-348) Reestablishing a Gold Standard Verification Rate for Pharmacists at an Acute Care Inpatient Pharmacy.
Favorite
12:00 PM – 1:00 PM
(3-349) Words Hurt Too: Use of Stigmatizing Language in People Who Inject Drugs
Favorite
12:00 PM – 1:00 PM
(3-350) Analyzing the Use of Direct-Acting Oral Anticoagulant in Fragile Population with Venous Thromboembolism and Atrial Fibrillation
Favorite
12:00 PM – 1:00 PM
(3-351) Multicenter Medication Use Evaluation of Intravenous Cangrelor for Bridge Therapy
Favorite
12:00 PM – 1:00 PM
(3-352) Analysis of Antibiotic Prescribing Habits Using the Collaboration to Harmonize Antimicrobial Registry Measure During Transitions of Care
Favorite
12:00 PM – 1:00 PM
(3-353) Utilizing Collaboration to Harmonize Antimicrobial Registry Measures (CHARM) Data to Assess Trends of Sexually Transmitted Infections in Outpatient Clinics
Favorite
12:00 PM – 1:00 PM
(3-354) Retrospective Observational Evaluation of N-acetylcysteine in the Treatment of Idiosyncratic Drug-Induced Liver Injury
Favorite
12:00 PM – 1:00 PM
(3-355) Validation of CHARM Dashboard Using Electronic Medical Records
Favorite
12:00 PM – 1:00 PM
(3-356) Use of the Collaboration to Harmonize Antimicrobial Registry Measures (CHARM) Database to Assess Concordance of Pediatric Amoxicillin-Clavulanate Suspension Formulation Selection and Dosing Regimen
Favorite
12:00 PM – 1:00 PM
(3-357) Low Rate of Concordant Antibiotic Selection among Ambulatory Patients with Renal Impairment
Favorite
12:00 PM – 1:00 PM
(3-358) Unveiling the Hidden Interaction: A Retrospective Analysis of Gastric Acid Suppressants and Anticancer Therapies
Favorite
12:00 PM – 1:00 PM
(3-359) Introducing a Corticosteroid Standard of Care for Immune-Related Adverse Events at a Cancer Outpatient Center
Favorite
12:00 PM – 1:00 PM
(3-360) Comparing infusion reactions for 2- vs 3.5-hour ocrelizumab infusions in patients with multiple sclerosis
Favorite
12:00 PM – 1:00 PM
(3-361) Infectious Outcomes After Chimeric Antigen Receptor (CAR) T-Cell Therapy for Lymphoma
Favorite
12:00 PM – 1:00 PM
(3-362) Assessing Socioeconomic Health Disparities in the Treatment and Outcomes of Cirrhosis Patients with Hepatic Encephalopathy
Favorite
12:00 PM – 1:00 PM
(3-363) The Feasibility of Continuous Cefepime Infusions in the Setting of Pediatric Sepsis
Favorite
12:00 PM – 1:00 PM
(3-364) Hypertension Awareness and Salt Related Behavior Among Adults in the United States
Favorite
12:00 PM – 1:00 PM
(3-365) Increase in Voluntary Risk Reporting with Patient Own Medications
Favorite
12:00 PM – 1:00 PM
(3-366) Implementation of a Triage Technician Position in the Outpatient Pharmacy at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-367) Continuation of ICU-Initiated Diltiazem in Survivors of Critical Illness
Favorite
12:00 PM – 1:00 PM
(3-368) Reduction in the Risk for Hospitalizations Associated with Beta-blockers in Self-identified Black and White Patients with HFrEF
Favorite
12:00 PM – 1:00 PM
(3-369) Cost Analysis of Ganciclovir IV Versus Valganciclovir Use Post-Lung Transplant
Favorite
12:00 PM – 1:00 PM
(3-370) Assessing the Impact of Implementing a Meds-to-Beds Pilot Service on Patient and Staff Satisfaction
Favorite
12:00 PM – 1:00 PM
(3-371) Hypertension At-Home and Self Monitoring: Correlations with Race, Ethnicity and Economic Status
Favorite
12:00 PM – 1:00 PM
(3-372) Real-World Clinical Outcomes for Patients Prescribed Liraglutide for Weight Loss by their Primary Care Provider at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-373) Evaluating the Impact of an Electronic Best Practice Alert on Facilitation of a Patient Referral Process to Clinical Specialty Pharmacists at the Point of Prescribing
Favorite
12:00 PM – 1:00 PM
(3-374) Rate of Pneumococcal, Tetanus, and Shingles Vaccination Among Adults 50 Years and Older: 2019 Behavioral Risk Factor Surveillance System (BRFSS)
Favorite
12:00 PM – 1:00 PM
(3-375) Increasing use of SGLT2 inhibitors in nephrology clinics at an academic medical center
Favorite
12:00 PM – 1:00 PM
(3-376) Clinical Outcomes of Condensed Versus Standard Schedule High-Dose Cytarabine in Patients with Acute Myeloid Leukemia
Favorite
12:00 PM – 1:00 PM
(3-377) Characterizing Access for Oral Oncolytics Used to Treat Breast Cancer at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(3-378) No Association between NUDT15 Genotype and Toxicity of Valganciclovir and Ganciclovir
Favorite
12:00 PM – 1:00 PM
(3-379) Evaluation of Outcomes of 2-Day vs 3-Day Lymphodepleting Regimens for CAR-T Cell Therapy in Patients with Non-Hodgkin’s Lymphoma
Favorite
12:00 PM – 1:00 PM
(3-380) Impact of Medication Management Training for Caregivers of People with Disabilities
Favorite
12:00 PM – 1:00 PM
(3-381) Assessing the Center for Medicare and Medicaid's (CMS) Payment Reduction Program on the Prevalence of Hospital-Acquired Conditions; 2018 and 2020
Favorite
12:00 PM – 1:00 PM
(3-382) Determining the association of Nudix-T-hydrolase (NUDT15) genotype with the efficacy of ganciclovir/valganciclovir in transplant recipient
Favorite
12:00 PM – 1:00 PM
(3-383) Characterizing Infusion Reactions to Cancer Treatments in Relationship to COVID-19
Favorite
12:00 PM – 1:00 PM
(3-384) Impact of Adverse Childhood Experiences on Marijuana Use among Adults in the U.S.
Favorite
12:00 PM – 1:00 PM
(3-385) Examining the Acceptance of Pharmacist-Driven Pharmacogenomic Testing Recommendations in Patient Care Plans
Favorite
12:00 PM – 1:00 PM
(3-386) Pharmacometabolomics Of Bioplar Disorder Treatments: Setting the Stage for Percision Health in Psychiatriy
Favorite
12:00 PM – 1:00 PM
(3-387) Clinical Pharmacist Outpatient Visits as Part of Pediatric Cystic Fibrosis Care: From Pandemic Lockdown to Community Reopening
Favorite
12:00 PM – 1:00 PM
(3-388) Impact of Mental Health Conditions and Therapies in Intensive Care Unit (ICU) Survivors
Favorite
12:00 PM – 1:00 PM
(3-389) Effects of Fenofibrate, Gemfibrozil, Lithium, and Valproic Acid on Chemotherapy-Induced Peripheral Neuropathy
Favorite
12:00 PM – 1:00 PM
(3-390) Assessment of Evidence-based Dosing Strategy to Achieve Vancomycin Area Under the Curve Targets in Pediatric Patients
Favorite
12:00 PM – 1:00 PM
(3-391) Review of Kidney Transplant Patients Receiving Belatacept-Based Maintenance Immunosuppression and the Incidence of Cytomegalovirus Infection
Favorite
12:00 PM – 1:00 PM
(3-392) Soy What? Risk factors associated with primary bloodstream infections in adult patients receiving parenteral nutrition – does lipid formulation matter?
Favorite
12:00 PM – 1:00 PM
(3-393) Pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) at discharge from an academic medical center: Do we get it right?
Favorite
2:00 PM – 3:30 PM
ASHP Best Practices Award Posters
2:00 PM – 3:30 PM
(4-083) Health System Biosimilar Selection Strategy Driven by Payor Specific Reimbursement
Favorite
2:00 PM – 3:30 PM
(4-085) ) Improved Access and Outcomes for Patients with Interstitial Lung Disease in a Pharmacist-Led Medication Management Program
Favorite
2:00 PM – 3:30 PM
(4-087) Real-world Clinical Impact of an In-house Dihydropyrimidine Dehydrogenase (DPYD) Genotyping Test on Fluoropyrimidine Dosing and Toxicity at a Multisite Cancer Center
Favorite
2:00 PM – 3:30 PM
(4-089) Development and Implementation of a Pharmacy Technician Leadership Residency Program
Favorite
2:00 PM – 3:30 PM
(4-091) Development and Implementation of an Oral Drug Repository Program
Favorite
2:00 PM – 3:30 PM
(4-093) Expanding Access and Elevating Care: The Success of the Pharmacotherapy Clinics Across a Community Hospital Healthcare System
Favorite
2:00 PM – 3:30 PM
Professional Posters
2:00 PM – 3:30 PM
(4-001) Utilizing a Plan-Do-Study-Act System to Implement USP at a Central-Fill Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-002) Utilization of a Healthcare Failure Mode and Effect Analysis to Optimize the Management of Narcotic Injectable in Pharmacy
Favorite
2:00 PM – 3:30 PM
(4-003) Implementation of a CPOE Dispensation Dashboard & ADC Focused Dispensation Model to Achieve Operational Efficiency at a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-004) Assessment of Blood Pressure and Body Mass Index in Low-Income Uninsured Patients with Diabetes in a Community Free Clinic
Favorite
2:00 PM – 3:30 PM
(4-006) Impact of Clinical and Specialty Pharmacy Services on Hepatitis B Virus Treatment Optimization
Favorite
2:00 PM – 3:30 PM
(4-007) Impact of an Ambulatory Care Pharmacist-Led Medication Refill Management Service in Primary Care
Favorite
2:00 PM – 3:30 PM
(4-008) Alpha-Fetoprotein Improvement and Association of Comorbidities Treatment Follow-Up in Patients with Chronic Liver Diseases
Favorite
2:00 PM – 3:30 PM
(4-009) Analysis of an Influenza Vaccination Quality Improvement Initiative in a Rural Federally Qualified Healthcare Center
Favorite
2:00 PM – 3:30 PM
(4-010) Applying Implementation Science to a Formalized Proposal of Optimizing Transitions of Care as a Part of Anticoagulation Stewardship
Favorite
2:00 PM – 3:30 PM
(4-011) Pharmacist-Led Care in Collaboration with a Cardiovascular Team to Improve the Management of Atherosclerotic Cardiovascular Disease Risk in Hospitalized Patients
Favorite
2:00 PM – 3:30 PM
(4-012) Evaluation of the Appropriate Use of Amiodarone for Atrial Fibrillation (AF) Prophylaxis in Post Coronary Artery Bypass Graft (CABG) Surgery Patients
Favorite
2:00 PM – 3:30 PM
(4-013) The Impact of Social Determinants of Health on Medication Adherence in a Medicare Advantage Population
Favorite
2:00 PM – 3:30 PM
(4-014) Implementation of a Proactive Affordability Program for Incretin Mimetics Prescribed to Medicare Patients: A Cross-Sectional Analysis of a Single Primary Care Clinic
Favorite
2:00 PM – 3:30 PM
(4-015) Implementation of Unit-Based Clinical Pharmacists in a 350 Bed Hospital in Los Angeles, CA
Favorite
2:00 PM – 3:30 PM
(4-016) Improvement in Glycemic Outcomes with Pharmacist Management of Insulin: Inpatient Behavioral Health Facility
Favorite
2:00 PM – 3:30 PM
(4-017) Value of Clinical Pharmacists in Preventing and Mitigating Patient Harm Associated with Drug-Related Problems in a Dermatology Drug Information Services Unit
Favorite
2:00 PM – 3:30 PM
(4-018) Implementation and Evaluation of a Pilot Meds to Beds Program in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-019) Pharmacists’ Role in Advancing Health Equity for Persons with Chronic Disease
Favorite
2:00 PM – 3:30 PM
(4-020) Improving Preparation Time, Safety, and Cost-Effectiveness of a Lung Cancer Drug by Using an FDA Approved Liquid Formulation: An Academic Oncology Hospital Study
Favorite
2:00 PM – 3:30 PM
(4-021) Physicochemical and Microbiological Stability of Tacrolimus Oral Compounded Suspensions
Favorite
2:00 PM – 3:30 PM
(4-022) Revamping a Sterile Compounding Master Formulation Record (MFR) Template Within a Large Integrated Health System to Align with United States Pharmacopeia (USP) 797 Updates
Favorite
2:00 PM – 3:30 PM
(4-023) Assessment of Intravenous to Oral Medications Conversion Practices in an Intensive Care Unit (ICU): A Retrospective Observational Study
Favorite
2:00 PM – 3:30 PM
(4-024) Comparing Outcomes in Hemorrhagic Stroke Patients Receiving Andexanet Alfa versus Four-Factor Prothrombin Complex for Reversal of Apixaban or Rivaroxaban
Favorite
2:00 PM – 3:30 PM
(4-025) Postgraduate Health Equity and Systems Thinking Pharmacy Fellowship Program
Favorite
2:00 PM – 3:30 PM
(4-026) Exploring Diverse Careers Within the Pharmaceutical Industry: An Interprofessional Discussion Among Historically Black Colleges and Universities (HBCUs) Medical and Pharmacy Students
Favorite
2:00 PM – 3:30 PM
(4-027) Comparative Evaluation of Educational Sessions on Vaccination & Preventable Diseases in an Older Adult Population
Favorite
2:00 PM – 3:30 PM
(4-028) Inquires About Allergens in Medicines: Experience from the National Drug Information Center of Costa Rica
Favorite
2:00 PM – 3:30 PM
(4-029) Development of an Acuity Scoring System to Mitigate Drug Shortages and Increase Supply Chain Resiliency
Favorite
2:00 PM – 3:30 PM
(4-030) Posaconazole Therapeutic Drug Monitoring in Adult Patients with Hematologic Malignancies in South Korea
Favorite
2:00 PM – 3:30 PM
(4-031) Assessment of Oral Vancomycin for Secondary Prophylaxis of Clostridioides Difficile Infection (CDI) in Hospitalized Patients Requiring Systemic Antimicrobial Therapy (SAT)
Favorite
2:00 PM – 3:30 PM
(4-032) Analysis of Prescriptions Containing Inappropriate Medications for the Elderly
Favorite
2:00 PM – 3:30 PM
(4-033) Evaluation of Nirmatrelvir/rRtonavir Use in Skilled Nursing Facility Residents During the COVID-19 Pandemic
Favorite
2:00 PM – 3:30 PM
(4-034) Association Between Polypharmacy and Falls in the Hospitalized Patients
Favorite
2:00 PM – 3:30 PM
(4-035) Cirrhotic Surveillance Utilizing FIB-4 Scores Among Incarcerated HCV Treated and Non-Treated Patients
Favorite
2:00 PM – 3:30 PM
(4-036) Comparing the Efficacy of Remdesivir, Nirmatrelvir-Ritonavir and Molnupiravir in Hospitalized Patients with Mild to Moderate COVID-19
Favorite
2:00 PM – 3:30 PM
(4-037) Effect of COVID-19 Infection on Risk for Acute Appendicitis
Favorite
2:00 PM – 3:30 PM
(4-038) Impact of Diagnostic Stewardship, Rapid Diagnostics, and Order Set Interventions on Anti-Pseudomonal Antibiotic Usage
Favorite
2:00 PM – 3:30 PM
(4-039) Impact of a Pharmacist-Driven Carbapenem De-Escalation Algorithm for Hospitalized Patients with Urinary Tract Infections
Favorite
2:00 PM – 3:30 PM
(4-040) Assessment of the Efficacy and Safety of Favipiravir in Patients with Coronavirus Infectious Disease 2019 (COVID-19) in United Arab Emirates: A Single-Center Study
Favorite
2:00 PM – 3:30 PM
(4-041) Implementation of Vancomycin AUC/MIC Monitoring for a Community Teaching Hospital
Favorite
2:00 PM – 3:30 PM
(4-043) Assessment of Fidaxomicin Within a Long-Term Acute Care Hospital (LTACH) System After Implementation of a Restriction Program
Favorite
2:00 PM – 3:30 PM
(4-044) Development of an Electronic Temperature Database for an Investigational Drug Service
Favorite
2:00 PM – 3:30 PM
(4-045) Impact of Alternative Medication Alerts in Ambulatory Prescribing
Favorite
2:00 PM – 3:30 PM
(4-046) Evolution of Leadership in the Profession of Pharmacy and Pharmacy Education
Favorite
2:00 PM – 3:30 PM
(4-047) Efficacy and Safety of BEP Chemotherapy Regimen for the Treatment of Yolk Sac Tumor in a Pregnant Patient — A Case Report
Favorite
2:00 PM – 3:30 PM
(4-048) Three Cases of Fever After Using Oxaliplatin
Favorite
2:00 PM – 3:30 PM
(4-049) Olaparib Use Evaluation: Real World Data in a Tertiary Care Hospital in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(4-050) Opioid Utilization in 72 Hour Period Following Cesarean Section: Effectiveness of Liposomal Bupivacaine, Acetaminophen, and Ketorolac
Favorite
2:00 PM – 3:30 PM
(4-051) Comparative Efficacy of Intravenous Acetaminophen and Tramadol in Postoperative Analgesia for Gastro-Related Surgeries
Favorite
2:00 PM – 3:30 PM
(4-052) Predictors of Opioid Use Before and After Orthopaedic Surgery in an Australian Setting: A Multi-Center, Cross-Sectional, Observational Study
Favorite
2:00 PM – 3:30 PM
(4-053) Prescription Intervention Activities by Pharmacists for Pediatric Patients in Korea
Favorite
2:00 PM – 3:30 PM
(4-054) Incidence of Gastrointestinal Bleeding with Hydrocortisone in Neonates and Infants Less Than Three Months of Age in the Neonatal Intensive Care Unit
Favorite
2:00 PM – 3:30 PM
(4-055) Evaluation of Single-Level Monitoring of Gentamicin Therapy in Neonates Using Bayesian Estimation Software
Favorite
2:00 PM – 3:30 PM
(4-056) Development of Renal Dysfunction Due to Vancomycin Hydrochloride and the Effect of Urinary Albumin
Favorite
2:00 PM – 3:30 PM
(4-057) Potential to Strengthen the Antimicrobial Stewardship Efforts by Advanced Pharmacy Practice Experience Students in a Tertiary Care Hospital in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(4-058) Assessing the Impact of Homework Quizzes on Student Preparation and Confidence for Top 300 Drug Exams
Favorite
2:00 PM – 3:30 PM
(4-059) Positive Impact of Technology-Based Learning Content in a Clinical Pharmacist Training Program
Favorite
2:00 PM – 3:30 PM
(4-060) Concomitant Use of Clozapine and Nirmatrelvir/Ritonavir at an Inpatient Psychiatric Facility
Favorite
2:00 PM – 3:30 PM
(4-061) Medication Use Evaluation of Lithium in Adults at a Long-Term State Psychiatric Facility
Favorite
2:00 PM – 3:30 PM
(4-062) Factors Affecting Antidepressant Medications Adherence in Saudi Arabia After the COVID-19 Pandemic
Favorite
2:00 PM – 3:30 PM
(4-063) Retrospective Safety Analysis of Olanzapine Administered Intravenously in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-064) Strategies Toward Safer Use of Narcotic Drugs: Pharmacist-Led Implementation of Narcotics Management Programs
Favorite
2:00 PM – 3:30 PM
(4-065) Impact of a Clinical Pharmacist in an Outpatient Dermatology Clinic
Favorite
2:00 PM – 3:30 PM
(4-066) Leveraging Barcode Scanning Technology for Enhanced Patient Safety in the Emergency Department: A Collaborative Approach and Process Improvement
Favorite
2:00 PM – 3:30 PM
(4-067) Identification and Management of Safety Gaps with Gemcitabine Bladder Irrigations
Favorite
2:00 PM – 3:30 PM
(4-069) Evaluation of Compliance with New Glycemic Clinical Quality Measures at a Community Hospital
Favorite
2:00 PM – 3:30 PM
(4-070) Iron Sucrose Infusion Reactions — Is There a Dose-Response Relationship?
Favorite
2:00 PM – 3:30 PM
(4-071) Quantifying Health-System Specialty Pharmacists’ Interventions for Patients Utilizing External Pharmacies
Favorite
2:00 PM – 3:30 PM
(4-072) Evaluation of Patients’ Perceptions on Switching from Reference Product Adalimumab to Biosimilar Adalimumab-Atto
Favorite
2:00 PM – 3:30 PM
(4-073) Post-Operative Urinary Retention Associated with Neuromuscular Blockade Reversal Agent in the United States Hospital Setting
Favorite
4:15 PM – 5:15 PM
Student Posters
4:15 PM – 5:15 PM
(5-001) Co-prescribing of acid suppressants with Cefpodoxime and potential for treatment failure
Favorite
4:15 PM – 5:15 PM
(5-002) Sterile Product Preparation of Patient-Controlled Analgesia Cassettes vs. Alternative Methods: A Financial Analysis
Favorite
4:15 PM – 5:15 PM
(5-003) Time to Oral Oncolytic Start in the Neuro-Oncology Patient Population
Favorite
4:15 PM – 5:15 PM
(5-004) Aggregate Analysis of Select US Health Systems and Hospitals of Potentially At-Risk IBD Patients Treated with Infliximab and Adalimumab Identified with Therapeutic Drug Monitoring
Favorite
4:15 PM – 5:15 PM
(5-005) Evaluating the Utilization of an Emergency Department Buprenorphine/naloxone Order Set
Favorite
4:15 PM – 5:15 PM
(5-006) Evaluating the Outcomes of a Pharmacy Intervention on the Management of Uncomplicated Gram-Negative Bacteremia
Favorite
4:15 PM – 5:15 PM
(5-007) Hypophysitis Presenting as Meningoencephalitis Secondary from IRAE
Favorite
4:15 PM – 5:15 PM
(5-008) Aseptic Meningitis Secondary to Keytruda Therapy
Favorite
4:15 PM – 5:15 PM
(5-009) Assessment of the workflow and time to antibiotic dose adjustment for critically ill patients starting continuous renal replacement therapy
Favorite
4:15 PM – 5:15 PM
(5-010) Evaluation of Pediatric Busulfan Dosing and Therapeutic Under the Curve (AUC) Data
Favorite
4:15 PM – 5:15 PM
(5-011) Evaluation of Hepatic Dosing Guidance in Epic
Favorite
4:15 PM – 5:15 PM
(5-012) Assessing the Incidence of Hypoglycemia with the Use of Lantus
Favorite
4:15 PM – 5:15 PM
(5-013) Effects of intravenous beta-lactam antibiotic infusion rates on clinical response: an analysis
Favorite
4:15 PM – 5:15 PM
(5-014) Evaluation of Cangrelor Use in the Neurointerventional Population
Favorite
4:15 PM – 5:15 PM
(5-015) Evaluation of Phenobarbital Use for Alcohol Withdrawal Treatment in Non-Critically Ill and Non-Emergency Department Adult Patients at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-016) Analysis of the Effect of Intravenous Beta-Lactam Infusion Rate on 28-day Mortality
Favorite
4:15 PM – 5:15 PM
(5-017) Impact of Preoperative Anxiety and Depression on Chronic Postoperative Opioid Use in Orthopedic Surgery Patients
Favorite
4:15 PM – 5:15 PM
(5-018) Evaluating the Use of Quetiapine Initiated for ICU Delirium Continued at Hospital Discharge
Favorite
4:15 PM – 5:15 PM
(5-020) Pregabalin Utilization at an Academic Pediatric Hospital
Favorite
4:15 PM – 5:15 PM
(5-021) Evaluation of Aminoglycoside Dosing in Critically Ill Patients on Continuous Renal Replacement Therapy
Favorite
4:15 PM – 5:15 PM
(5-023) Evaluation of Pharmacy Student Led Education for Compliance to a Critical Care Medication Titration Protocol
Favorite
4:15 PM – 5:15 PM
(5-024) Review of Medication Classes and Reasons for Decline in Medication Adherence Rates: A Population Health Approach
Favorite
4:15 PM – 5:15 PM
(5-025) Effect of Perioperative Pregabalin on Opioid Requirements for Open-heart Surgery
Favorite
4:15 PM – 5:15 PM
(5-026) Pharmacist-Led Hypertension Management Outcomes in an Ambulatory Care Setting
Favorite
4:15 PM – 5:15 PM
(5-027) Effect of Strict Preoperative Antibiotic Allergy Substitution Protocol on Proper Antibiotic Selection
Favorite
4:15 PM – 5:15 PM
(5-028) Review of Acute ITP Management at a Large Academic Health System
Favorite
4:15 PM – 5:15 PM
(5-029) Medication Use Evaluation of Sodium Zirconium Cyclosilicate in Acute Hyperkalemia
Favorite
4:15 PM – 5:15 PM
(5-030) Assessing Indomethacin Suppository Cost Versus Savings for Hospital Pharmacy
Favorite
4:15 PM – 5:15 PM
(5-031) Evaluation of Outpatient Post-Operative Pain Control with Scheduled Acetaminophen and as Needed Opioid Use in a General Surgical Population at a Metropolitan Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-032) Inpatient Pharmacy Preparation and Dispensing of Basal Insulin
Favorite
4:15 PM – 5:15 PM
(5-033) Thromboelastography Utilization in Coagulation Status for Patients on Direct Oral Anticoagulants (DOACs) Requiring Emergent Reversal
Favorite
4:15 PM – 5:15 PM
(5-034) Medication Use Evaluation of Fondaparinux in Heparin Induced Thrombocytopenia (HIT)
Favorite
4:15 PM – 5:15 PM
(5-035) Comparison of Fentanyl Products on Cost, Waste, and Compliance with Controlled Substance Management Policy at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-036) Pharmacy Involvement in a Sepsis Improvement Pilot
Favorite
4:15 PM – 5:15 PM
(5-037) Evaluation of Calcium Replacement on Hypocalcemia in Trauma Patients Receiving Massive Transfusion Protocol
Favorite
4:15 PM – 5:15 PM
(5-038) Evaluation of Amisulpride Use at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-039) Evaluating Outcomes of semaglutide and liraglutide in Patients with Type 2 Diabetes
Favorite
4:15 PM – 5:15 PM
(5-040) Assessing Inpatient Psychiatric Patient Medication Education Groups (PMEGs): Evaluation of an Adaptive Curriculum to Meet Patient Educational Needs and Documentation Practices
Favorite
4:15 PM – 5:15 PM
(5-041) Med Rec Double Check: Inpatient Psychiatry Medication Errors Identified on Admission Using Medicaid Web Portals and Electronic Pharmaceutical Claims Data
Favorite
4:15 PM – 5:15 PM
(5-042) Hypertriglyceridemia After Lipid Emulsion Infusion in Low Birth Weight and Very Premature Neonates
Favorite
4:15 PM – 5:15 PM
(5-043) Evaluation of Pharmacist-led Protocol for the Management of Hypertonic Saline for Acute Cerebral Edema in Neurocritical Care Patients
Favorite
4:15 PM – 5:15 PM
(5-044) Evaluation of Enoxaparin Dosing Protocol in Trauma Patients at a Single Level Two Trauma Center
Favorite
4:15 PM – 5:15 PM
(5-045) Anticoagulant Reversal Agent on Formulary: An Evaluation of the Suitability of Adding Andexanet Alfa to a Critical Access Hospital Formulary
Favorite
4:15 PM – 5:15 PM
(5-046) Leading Factors of Pharmacy Technician Turnover Intention in Nebraska
Favorite
4:15 PM – 5:15 PM
(5-047) Epidemiology of Enterobacterales Bacteremia and Antimicrobial Resistance Genes Using Rapid Culture Identification Panel at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-048) A Qualitative Study Examining PGY-2 Informatics Residency Program Directors’ Perspectives about Informatics Training
Favorite
4:15 PM – 5:15 PM
(5-049) Cephalexin-Induced Leukocytoclastic Vasculitis in a Patient Undergoing Treatment for Cellulitis
Favorite
4:15 PM – 5:15 PM
(5-050) Predictors and Adverse Outcomes Associated with Blood Culture Contamination: A Retrospective Cohort Study
Favorite
4:15 PM – 5:15 PM
(5-051) Ceftriaxone Pharmacokinetics in Obese Compared to Non-Obese Intensive Care Unit (ICU) Patients
Favorite
4:15 PM – 5:15 PM
(5-052) Evaluating the Impact of a Student Pharmacist-led Model for Initiating Statin Therapy in Patients with Type 2 Diabetes.
Favorite
4:15 PM – 5:15 PM
(5-053) Evaluation of Naloxone Retrieval by Patients who were Prescribed Opioids upon Discharge from Nebraska Medicine
Favorite
4:15 PM – 5:15 PM
(5-054) Blood Pressure Management Trends with use of Nicardipine in Patients with Spontaneous Intracerebral Hemorrhage
Favorite
4:15 PM – 5:15 PM
(5-055) Assessment of Four-factor Prothrombin Complex Concentrate Use for the Reversal of Apixaban and Rivaroxaban in Intracranial Hemorrhage at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-056) Effect of Mean Arterial Goals on Utilization of Norepinephrine at Nebraska Medicine
Favorite
4:15 PM – 5:15 PM
(5-057) Evolution of Mpox Virus: an Epidemiological Study and Overview
Favorite
4:15 PM – 5:15 PM
(5-058) Exploring the Effects of Amlexanox Post Cisplatin Treatment on Cervical HeLa Cancer Cells
Favorite
4:15 PM – 5:15 PM
(5-059) Effects of G Protein Coupled Receptor Kinase 2 on MDA MB 231 Cells Exposed to Doxorubicin and Paroxetine
Favorite
4:15 PM – 5:15 PM
(5-060) Investigating the effects of Ondansetron with TAC regimen on MDA MB 231 cells
Favorite
4:15 PM – 5:15 PM
(5-061) Exploring the Influence of Dopamine Using Caenorhabditis elegans as an Experimental Model
Favorite
4:15 PM – 5:15 PM
(5-062) Exploring the Effects of G-Protein Coupled Receptor Kinase 5 on Osteosarcoma Cell Adhesion
Favorite
4:15 PM – 5:15 PM
(5-063) Investigating the Effects of Amlexanox Treatment Prior to Cisplatin on Cervical Cancer Cells
Favorite
4:15 PM – 5:15 PM
(5-064) Alvimopan Use for Postoperative Ileus
Favorite
4:15 PM – 5:15 PM
(5-065) Euglycemic diabetic ketoacidosis secondary to Sodium Glucose 2 Transport Inhibitor: a case report
Favorite
4:15 PM – 5:15 PM
(5-066) Testing C. elegans as an Experimental Model for Dopamine agonist effectiveness in Parkinson’s Disease
Favorite
4:15 PM – 5:15 PM
(5-067) Long-Term Neurological Involvement in COVID-19 Patients
Favorite
4:15 PM – 5:15 PM
(5-068) Testing Potential Compounds Derived from MI-4 (Ro-25-6981) Against Monoamine Transporters
Favorite
4:15 PM – 5:15 PM
(5-069) COVID-19 Variants and Vaccine Efficacy
Favorite
4:15 PM – 5:15 PM
(5-070) Exploring the Effects of Doxorubicin on Osteosarcoma U2OS Cells without G protein Coupled Receptor Kinase 5: Recovery and Colony Formation
Favorite
4:15 PM – 5:15 PM
(5-071) Exploring the Use of Essential Oils for Protection and Treatment from Hyperosmotic Stress in C. elegans
Favorite
4:15 PM – 5:15 PM
(5-072) Exploring ERK1/2 and STAT3 Expression in Rat Cardiomyocytes Treated with Doxorubicin or Etoposide
Favorite
4:15 PM – 5:15 PM
(5-073) Ophthalmic Drug Delivery Using 3D-Printed Hydrogels with Covalently Bound Drugs
Favorite
4:15 PM – 5:15 PM
(5-074) Exploring the Toxic Effects of Doxorubicin and Etoposide in Rat Cardiomyocytes
Favorite
4:15 PM – 5:15 PM
(5-075) Glutamatergic and Serotonergic Mechanisms of Novel Analogs of the Ketamine-like Rapid-acting Antidepressant RO-25-6981
Favorite
4:15 PM – 5:15 PM
(5-076) Detection and Relative Quantitation of mRNA of Tissue Matrix Metalloproteases (MMPs) after Exposure to Doxorubicin in In Vitro Cell Cultures
Favorite
4:15 PM – 5:15 PM
(5-077) Detection and Relative Quantitation of mRNA of Tissue Inhibitors of Matrix Metalloproteases (TIMPs) after Exposure to Doxorubicin in In Vitro Cell Cultures
Favorite
4:15 PM – 5:15 PM
(5-078) Evaluation of the 2021 Roseman Basics Leveling Course - Survey and Focus Group Results
Favorite
4:15 PM – 5:15 PM
(5-079) Detection and Relative Quantitation of Changes in Gene Expression of HIPPO Proteins in Doxorubicin-Exposed Human Cells by RT-qPCR
Favorite
4:15 PM – 5:15 PM
(5-080) Explore the Relationship between G protein Coupled Receptor Kinases and Colorectal Cancer Progression
Favorite
4:15 PM – 5:15 PM
(5-081) Fighting the Opioid Crisis Through Information: A Preliminary Assessment of the NH PDMP’s Effectiveness
Favorite
4:15 PM – 5:15 PM
(5-082) Clinical Trial Variations Amongst Investigational and Recently Approved Drugs for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome
Favorite
4:15 PM – 5:15 PM
(5-083) Efficacy and Safety of EGFR-targeted Therapies for Asian, Females, and Non-Smokers with EGFR-sensitizing Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review
Favorite
4:15 PM – 5:15 PM
(5-084) Scope and variability of cost-effectiveness studies involving bDMARDS in the treatment of methotrexate-refractory rheumatoid arthritis
Favorite
4:15 PM – 5:15 PM
(5-085) Evaluating the Evolution of Outcome Measures in Clinical Trials for Alzheimer’s Disease
Favorite
4:15 PM – 5:15 PM
(5-086) Overview of Risk Factors Associated with Clostridioides difficile Infection and Current/Emerging Therapies
Favorite
4:15 PM – 5:15 PM
(5-087) Evaluation of Hospital Discharge Opioid Prescriptive Patterns in Opioid-naïve Patients for Acute Pain
Favorite
4:15 PM – 5:15 PM
(5-088) Retrospective Utilization of Liposomal Bupivacaine in Patients Undergoing Cesarean Section
Favorite
4:15 PM – 5:15 PM
(5-089) Treatment Outcomes in Patients Receiving Iron Supplementations During the Treatment of Serious Infections
Favorite
4:15 PM – 5:15 PM
(5-090) Comprehensive Review of Immunotherapeutic Mechanisms of Actions in Phase II and III Metastatic Pancreatic Cancer Trials
Favorite
4:15 PM – 5:15 PM
(5-091) Evaluation of Interventions Implemented in Global Antimicrobial Stewardship Programs: A Literature-review
Favorite
4:15 PM – 5:15 PM
(5-092) Assessment of Expedited Discharge and Readmissions with Inpatient Oritavancin Administration
Favorite
4:15 PM – 5:15 PM
(5-093) Comparing Baseline Demographics of Patients with Chronic Lymphocytic Leukemia in Phase III Clinical Trials of Bruton’s Tyrosine Kinase Inhibitors and Real-World Global Data
Favorite
4:15 PM – 5:15 PM
(5-094) Cracking the Code: Machine Learning Predictions for Immunotherapy Efficacy and Cancer Progression in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
Favorite
4:15 PM – 5:15 PM
(5-095) Survey at a School of Pharmacy to Determine Time Spent in Preparation of Course Material
Favorite
4:15 PM – 5:15 PM
(5-096) Public Health Preparedness at a Community Teaching Hospital: A Case Report Detailing Malaria Diagnosis and Treatment
Favorite
4:15 PM – 5:15 PM
(5-097) Tranexamic Acid-Induced Tonic-Clonic Seizure Following Total Hip Replacement: A Case Report
Favorite
4:15 PM – 5:15 PM
(5-098) Evolution of Food and Drug Administration review comments for Non-Small Cell Lung Cancer product approvals over a 20-year period
Favorite
4:15 PM – 5:15 PM
(5-099) Impact of Vancomycin Loading Doses on Early Target Attainment
Favorite
4:15 PM – 5:15 PM
(5-100) Past, Present, and Future Implications of Artificial Intelligence in Pharmacovigilance: Literature Review
Favorite
4:15 PM – 5:15 PM
(5-101) Incidence and Predictors of Stroke Mimic Amongst Patients Treated with Tissue Plasminogen Activator: A Multi-Institutional Comparison of Stroke Mimic Prediction Tools in the Emergency Department
Favorite
4:15 PM – 5:15 PM
(5-102) Current Landscape of Cannabis and Cannabinoid Use for Symptom Management in Breast Cancer
Favorite
4:15 PM – 5:15 PM
(5-103) Evaluation of Clinical Trials for Pipeline Biosimilars and Analysis of Potential Wholesale Acquisition Cost Savings of Approved Biosimilars for Moderate to Severe Plaque Psoriasis
Favorite
4:15 PM – 5:15 PM
(5-104) Role of Pembrolizumab in Advanced Stage Melanoma
Favorite
4:15 PM – 5:15 PM
(5-105) Retrospective Study on SGLT-2 Inhibitor Discontinuation Rates for Inpatient Initiation
Favorite
4:15 PM – 5:15 PM
(5-106) Presence of Misinformation on Leading Patient Health Websites Addressing Medical Therapies in Uterine Fibroids and Endometriosis
Favorite
4:15 PM – 5:15 PM
(5-107) Literature Review of Investigational Drugs and Therapies Targeting the Centers for Disease Control and Prevention (CDC) “Urgent” US Bacterial Pathogens
Favorite
4:15 PM – 5:15 PM
(5-108) Evaluation of opioid consumption with and without the intraoperative administration of bupivacaine/meloxicam in total knee and total hip arthroplasty
Favorite
4:15 PM – 5:15 PM
(5-109) The Role of 15% Hypertonic Saline Irrigation in Treatment of Hepatic Hydatid Cysts
Favorite
4:15 PM – 5:15 PM
(5-110) Descriptive Analysis of CURE-ID: Exploring Repurposed Treatment Modalities for Managing Nontuberculous Mycobacterial Infection (NTM)
Favorite
4:15 PM – 5:15 PM
(5-111) Evaluating Incretin Mimetic Agents for Safety and Efficacy in Chronic Weight Management: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-112) Efficacy of Low Dose Levetiracetam for Status Epilepticus in Pediatric Patients: A Retrospective Study
Favorite
4:15 PM – 5:15 PM
(5-113) Multiple Opportunistic Infections in a Patient with Newly Diagnosed HIV: A Case Report
Favorite
4:15 PM – 5:15 PM
(5-114) Evaluating Variability in Phase III Trials of Adalimumab Biosimilars
Favorite
4:15 PM – 5:15 PM
(5-115) Trends in Social Media Impact on Youth Mental Health: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-116) Identifying and Analyzing Medication Errors for Patients with Enteral Feeding Tubes
Favorite
4:15 PM – 5:15 PM
(5-117) Evaluation of the Safety of Sodium-Glucose Cotransporter 2 Inhibitor Initiation in an Inpatient Post-Cardiothoracic Surgery Patient Population
Favorite
4:15 PM – 5:15 PM
(5-118) Review of Clinical Trial Enrollment Diversity in Children with Acute Lymphoblastic Leukemia
Favorite
4:15 PM – 5:15 PM
(5-119) Evaluation of Risk Versus Benefit Information in Direct-to-Consumer (DTC) Prescription Drug Television Advertisements
Favorite
4:15 PM – 5:15 PM
(5-120) A Review of NCCN Treatment Guideline Recommendations and Published Evidence for Refractory/Relapsed Pediatric Hodgkin and Aggressive Mature B-Cell Lymphomas vs. FDA Medication Approvals
Favorite
4:15 PM – 5:15 PM
(5-121) Evaluation of the effect of tolvaptan for the treatment of hyponatremia at a community hospital
Favorite
4:15 PM – 5:15 PM
(5-122) Revolutionizing Clinical Trials: The Efficiency and Diversity of Patient Recruitment Through Artificial Intelligence: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-123) Evaluation of Guideline Adherence to Erythropoietin Stimulating Agent Prescribing in End-Stage Renal Disease and Chronic Kidney Disease Patients: A Single-Center, Retrospective Analysis
Favorite
4:15 PM – 5:15 PM
(5-124) The Effect of Influenza and Pneumococcal Vaccines on Readmission and Mortality of Pneumonia Patients
Favorite
4:15 PM – 5:15 PM
(5-125) Effects of updating prandial insulin administration instructions on blood glucose levels
Favorite
4:15 PM – 5:15 PM
(5-126) Pharmacy Students’ Knowledge and Interest in Advocacy for the Profession of Pharmacy
Favorite
4:15 PM – 5:15 PM
(5-127) Molecular Dynamics Simulations to Screen Dihydrofolate Reductase Inhibitors Targeting Wuchereria Bancrofti
Favorite
4:15 PM – 5:15 PM
(5-128) Exploring the emergence of Artificial Intelligence in the Learning of Healthcare Students
Favorite
4:15 PM – 5:15 PM
(5-129) Evaluation of Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Non-Critically Ill Patients at a Large Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-130) Allergy Documentation Completed by Medication History Technicians Compared to Nurses and Impact on Anti-Infective and Pain Medication Prescribing in the Emergency Department
Favorite
4:15 PM – 5:15 PM
(5-131) Retrospective Evaluation of the Use of Rapid Diagnostic Testing for Bloodstream Infections in a Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-132) Developing and Assessing an Interprofessional Pharmacy Student Peer-Led Curriculum for Pre-Health Undergraduate Students
Favorite
4:15 PM – 5:15 PM
(5-133) Practical Applications of Precision Medicine in Psoriasis
Favorite
4:15 PM – 5:15 PM
(5-134) The Global Impact of COVID-19 on Opioid Use Post-Lockdown: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-135) Prescribing Practices at a Community Hospital for the Management of Clostridioides Dificile Infection
Favorite
4:15 PM – 5:15 PM
(5-136) Efficacy and Safety of Vancomycin DoseMeRx Dosing Software Versus Trough-Based Dosing in a Community Hospital: A Retrospective Cohort Study
Favorite
4:15 PM – 5:15 PM
(5-137) Comparing Fezolinetant and Hormone Therapy in the Treatment of Vasomotor Symptoms in Menopausal Women – A Review of the Literature
Favorite
4:15 PM – 5:15 PM
(5-138) Analysis of Outcome Measures Represented in Disease-Modifying Investigational Trials for Parkinson’s Disease Over 10 Years - A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-139) Effects of Implementing a Pneumonia Care Bundle on Hospital Readmission Rates Utilizing Pneumonia Severity
Favorite
4:15 PM – 5:15 PM
(5-140) Evaluation of Levetiracetam’s Effects on Behavioral Adverse Events in Patients with Spontaneous Intracerebral Hemorrhage Receiving Seizure Prophylaxis
Favorite
4:15 PM – 5:15 PM
(5-141) Number of PharmDs Entering Industry Upon Graduation from 2020-2022
Favorite
4:15 PM – 5:15 PM
(5-142) Chimeric Antigen Receptor T-Cell Therapy: Current Applications and Future Directions
Favorite
4:15 PM – 5:15 PM
(5-143) Polycystic Ovary Syndrome (PCOS): A Global 5-Year Literature Review of Non-Guideline Therapeutic Interventions
Favorite
4:15 PM – 5:15 PM
(5-144) Impact of Second Generation Antipsychotics on Renal Function: A Literature Review
Favorite
4:15 PM – 5:15 PM
(5-145) PTSD Medications and Future Treatments: A Comprehensive Literature Review of Approved, Investigational, and Off-Label Therapies
Favorite
4:15 PM – 5:15 PM
(5-146) Drug Pipeline for Chemotherapy and Radiation-Induced Oral Mucositis
Favorite
4:15 PM – 5:15 PM
(5-147) Controlling Hypertension in a Federally Qualified Health Center: Baseline Compliance with Guideline-Based Pharmacotherapy in a Randomized-Controlled Study
Favorite
4:15 PM – 5:15 PM
(5-148) Counting Costs with Chimeric Antigen Receptor (CAR) T-cell Therapy: Limitations Associated with Cost-Effectiveness Analyses in the United States
Favorite
4:15 PM – 5:15 PM
(5-149) Evaluation of Treatments in Hypercalcemia of Malignancy at an Academic Community Hospital
Favorite
4:15 PM – 5:15 PM
(5-150) Pharmacological Advancements in the Management of Pediatric Atopic Dermatitis: A Narrative Review of Clinical Trial Findings and Future Perspectives
Favorite
4:15 PM – 5:15 PM
(5-151) CAR-T Cell Therapy: A Review of Mechanisms of Action in Clinical Trials for the Treatment of Solid Tumors
Favorite
4:15 PM – 5:15 PM
(5-152) Effects of Cannabinoids for the Treatment of Cannabis Use Disorder: A Systematic Review
Favorite
4:15 PM – 5:15 PM
(5-153) A Supplemental Approach to β-Thalassemia: A Literature Review on the Impact of Vitamin Deficiencies and the Effect of Vitamin Supplementation
Favorite
4:15 PM – 5:15 PM
(5-154) Regulating Artificial Intelligence and Machine Learning in Clinical Care: Balancing Innovation and Harmonization
Favorite
4:15 PM – 5:15 PM
(5-155) The Variability of Intranasal Naloxone Dispensing and Prescribing Regulations Impacting Pharmacy Practice across the United States
Favorite
4:15 PM – 5:15 PM
(5-156) Comparing Effectiveness Between Different Antidepressants in Preventing Psychiatric Rehospitalization
Favorite
4:15 PM – 5:15 PM
(5-157) Retrospective Review of Prescribing Practices at Discharge for Patients with Type 2 Diabetes Admitted Due to an Atherosclerotic Cardiovascular Event
Favorite
4:15 PM – 5:15 PM
(5-158) Racial, Ethnic, and Socioeconomic Disparities in P2Y12 Inhibitor Prescribing Trends Following Percutaneous Coronary Intervention in Medicare Beneficiaries with Acute Coronary Syndrome
Favorite
4:15 PM – 5:15 PM
(5-159) Evaluation of Artificial Intelligence, Machine Learning, and Deep Learning-Based Prediction Models for Prognosis and Immunotherapy Response Predictions in Breast Cancer Patients; Literature Review
Favorite
4:15 PM – 5:15 PM
(5-160) Evaluating Trends in Current United States Drug Shortages Reported to the Federal Drug Administration: July 2020—September 2023
Favorite
4:15 PM – 5:15 PM
(5-161) Evaluation of FDA Approved Vaccines for Respiratory Syncytial Virus (RSV) in the United States
Favorite
4:15 PM – 5:15 PM
(5-162) Implementation of a Protocol for Post-Cesarean Delivery Oral Cephalexin and Metronidazole to Prevent Surgical Site Infection in Women with Obesity: a retrospective study
Favorite
4:15 PM – 5:15 PM
(5-163) Enterohormone Levels in Patients with HIV and Impact on Depression and Neurocognitive Assessments
Favorite
4:15 PM – 5:15 PM
(5-164) Utilizing Non-opioid Pain Medication for Total Knee Replacement Surgery in a Community Hospital in Southern New Mexico: A Comparison of Local Bupivacaine/meloxicam versus Ropivacaine Pump
Favorite
4:15 PM – 5:15 PM
(5-165) SAVED or Harmed? Appropriate Utilization of Anticoagulation in Multiple Myeloma Patients
Favorite
4:15 PM – 5:15 PM
(5-166) Evaluating Vaccine Hesitancy in Gender Expansive Patients
Favorite
4:15 PM – 5:15 PM
(5-167) Understanding Recurrent Migraine: A Dual Perspective from Patients and the Scientific Literature
Favorite
4:15 PM – 5:15 PM
(5-168) Neurocognitive impairment and assessments in patients with HIV
Favorite
4:15 PM – 5:15 PM
(5-169) Association of High-Risk Comorbidities in Patients with a Diagnosis of Gender Dysphoria in New Mexico
Favorite
4:15 PM – 5:15 PM
(5-170) Assessing Preferences for and Utilization of Advanced Care Planning in Individuals with Lynch Syndrome
Favorite
4:15 PM – 5:15 PM
(5-171) Opportunities for Inpatient Pharmacy Interventions: A Heart Failure Readmissions Descriptive Report
Favorite
4:15 PM – 5:15 PM
(5-172) Evaluation of Antifungal Prophylaxis and Risk of Invasive Fungal Disease for Patients with Acute Leukemia on Oral Anticancer Therapies with Significant CYP450 Drug Interactions
Favorite
4:15 PM – 5:15 PM
(5-173) Assessing Indications and Outcomes of 4F-PCC Treatment for Reversal of Apixaban and Rivaroxaban, Factor Xa Inhibitors
Favorite
4:15 PM – 5:15 PM
(5-174) Charting the Path: ACPHS PharmD Alumni's Journey to Success in the Pharmaceutical Industry
Favorite
4:15 PM – 5:15 PM
(5-175) Assessing the impact of role play on students’ perceived readiness to provide screening, brief intervention, and referral to treatment (SBIRT) services
Favorite
4:15 PM – 5:15 PM
(5-176) Appropriateness of Discontinuing Hydroxychloroquine (HCQ) in Patients With Suspected Retinal Toxicity: A Case Series
Favorite
4:15 PM – 5:15 PM
(5-177) Evaluation of Initial Daptomycin Dosing Regimens for Deep-Seated Gram-positive Infections
Favorite
4:15 PM – 5:15 PM
(5-178) Effect of penicillin MIC on treatment success of Enterococcus faecalis bacteremia
Favorite
4:15 PM – 5:15 PM
(5-179) Reasoning Behind Refusal of a Shingles Vaccination by Patients Enrolled in the Albany Stratton VA Rheumatology Clinic on Immunosuppressant Medications
Favorite
4:15 PM – 5:15 PM
(5-180) Evaluation of a Quality Initiative Intervention to Prevent Shingles in Rheumatology Patients Through the Recombinant Zoster Vaccine
Favorite
4:15 PM – 5:15 PM
(5-181) Retrospective Evaluation of LDL Reduction with Inclisiran at a Private Cardiology Practice
Favorite
4:15 PM – 5:15 PM
(5-182) Impact of a Herpes Zoster Vaccine Counseling Quality Improvement Intervention on an Immunocompromised Population: A Cost-Benefit Analysis
Favorite
4:15 PM – 5:15 PM
(5-183) Addressing stock-outs and dispense rates from pharmacy satellites by optimizing automated dispensing cabinets in an academic healthcare facility.
Favorite
4:15 PM – 5:15 PM
(5-184) Determining the Beyond-Use Date of Compounded 5-FU Ophthalmic Solution Using High-Pressure Liquid Chromatography
Favorite
4:15 PM – 5:15 PM
(5-185) Aduhelm: Revisiting the Phase 3 Clinical Trials and the FDA Approval Decision
Favorite
4:15 PM – 5:15 PM
(5-186) Assessing Pharmacy Students’ Interest in a Pharmacy Technology and Automation Certificate Program
Favorite
4:15 PM – 5:15 PM
(5-187) Novel Delivery-Platform Reduces Cardiac Toxicity of the FDA-approved BTK Inhibitors used in Blood Malignancies
Favorite
4:15 PM – 5:15 PM
(5-188) Streamlining Tray Restocking Time and Cost-Saving Utilization at Mount Sinai Hospital’s Operating Room Pharmacy with KitCheck
Favorite
4:15 PM – 5:15 PM
(5-189) Medicare Formulary Restrictions for Glucagon-Like Peptide-1 Agonists and Sodium-Glucose CoTransporter-2 Inhibitors used in T2DM, 2019-2023
Favorite
4:15 PM – 5:15 PM
(5-190) A Retrospective Feasibility Study Evaluating Bayesian Therapeutic Drug Monitoring Software at Predicting Phenobarbital Levels in the Critically Ill Population
Favorite
4:15 PM – 5:15 PM
(5-191) Identifying the Nuclear Localization Domain of Matrix Metalloproteinase-2: Implications for Cell Migration in Cancer Therapies
Favorite
4:15 PM – 5:15 PM
(5-192) Proteomic Methods to Screen Ixodes Scapularis in Broome County Parks for Potential Tick-Borne Pathogens
Favorite
4:15 PM – 5:15 PM
(5-193) Combinatorial Effects of Traditional Chemotherapy with Downregulation of the MYC and/or KRAS Oncogenes in Ovarian Cancer Cells
Favorite
4:15 PM – 5:15 PM
(5-194) Evaluation of major inpatient statin-drug interactions in inpatient older adults prescribed simvastatin compared to all other statins
Favorite
4:15 PM – 5:15 PM
(5-195) Enhancing the Responsiveness of High-grade B-cell Lymphoma to CHOP by Targeting MYC and/or Bcl-2
Favorite
4:15 PM – 5:15 PM
(5-196) Influence of State Restrictions on Opioid Prescribing: 2006 – 2018
Favorite
4:15 PM – 5:15 PM
(5-197) Investigating the Role of Mitochondrial Proteins in Post-Treatment Lyme Disease
Favorite
4:15 PM – 5:15 PM
(5-198) Development of a Thermal Shift Assay for Pseudomonas Aeruginosa Drug Discovery
Favorite
4:15 PM – 5:15 PM
(5-199) Outcomes Associated with the Prescription Use of Statins or Antiplatelets in Patients with Spectrums of Non-obstructive Coronary Artery Disease (NOCAD)
Favorite
4:15 PM – 5:15 PM
(5-200) Comparison of Adverse Drug Event and Medication Safety Event Rates in Supportive Oncology Biosimilars to the Reference Product
Favorite
4:15 PM – 5:15 PM
(5-201) Systematic Review of Treatment Protocols and Pathways for Patients Presenting to the Emergency Department with Vaso-Occlusive Pain Secondary to Sickle Cell Disease
Favorite
4:15 PM – 5:15 PM
(5-202) The Importance of Ensuring Continued Access to Continuous Glucose Monitoring Devices to Support Reduction in Insulin Requirements
Favorite
4:15 PM – 5:15 PM
(5-203) Systematic review of intrauterine contraceptive use and the development of toxic shock syndrome
Favorite
4:15 PM – 5:15 PM
(5-205) Analyzing the indication of use with regards to rivaroxaban 2.5 mg twice daily dosing in an inpatient setting.
Favorite
4:15 PM – 5:15 PM
(5-206) Bridging Clinical and Business Education in Pharmacy through Implementation of Corporate Pharmacy Experience Programs
Favorite
4:15 PM – 5:15 PM
(5-207) Assessing Standardized EVS Policies and Competencies to Enhance Safety and Compliance for Sterile and Hazardous Compounding Across Hospital Facilities
Favorite
4:15 PM – 5:15 PM
(5-208) Investigating the role of clinical pharmacy services in reducing readmission rates for high risk patient population
Favorite
4:15 PM – 5:15 PM
(5-209) Kidney Disease and Proton Pump Inhibitors: An Intertwined Relationship
Favorite
4:15 PM – 5:15 PM
(5-210) Characterizing Enterococcus faecalis Beta-Lactam Susceptibility across a New York City Health-System
Favorite
4:15 PM – 5:15 PM
(5-211) Assessing the Safety of a Beta-Lactam Allergy Protocol Utilizing Test Doses of Beta-Lactam Agents
Favorite
4:15 PM – 5:15 PM
(5-212) Effects of Urban Heat Islands on Pediatric Asthma Exacerbation: How Race Plays a Role
Favorite
4:15 PM – 5:15 PM
(5-213) Therapy Duplication of Dipeptidyl Peptidase 4 and Glucagon-Like-Peptide-1 Receptor Agonists: A Medication Use Evaluation
Favorite
4:15 PM – 5:15 PM
(5-214) Concordance of International Pharmacogenomic Recommendations: A Comparative Analysis of Five Pharmaceutical Regulatory Agencies
Favorite
4:15 PM – 5:15 PM
(5-215) Assessment of Documented Bacterial Infections and Antibiotic Utilization in Chimeric Antigen Receptor (CAR-T) Cell Therapy in Multiple Myeloma Patients
Favorite
4:15 PM – 5:15 PM
(5-217) Crushability Analysis of Immediate-Release Oral Tablets and Capsules Approved by Food and Drug Administration in 2020-2022.
Favorite
4:15 PM – 5:15 PM
(5-218) Cancer immunotherapy and the role of combination adjuvants
Favorite
4:15 PM – 5:15 PM
(5-219) Potential Role of Curcumin in Age-related Macular Degeneration: a Review
Favorite
4:15 PM – 5:15 PM
(5-220) Retrospective Analysis of Naloxone Infusion Initiation on Intravenous Diphenhydramine Usage in Sickle Cell Patients Hospitalized for Pain Crisis in a 261-bed Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-222) Stability of Vinblastine in Polyolefin Intravenous Piggyback (IVPB)
Favorite
4:15 PM – 5:15 PM
(5-223) Antimicrobial Stewardship Strategies in Sepsis and Septic Shock Patients
Favorite
4:15 PM – 5:15 PM
(5-224) Pregnancy Registry Information in Generic Drug Labels: A Retrospective Analysis of Atypical Antipsychotics, Antidepressants, ADHD, and Insomnia Medications
Favorite
4:15 PM – 5:15 PM
(5-225) Nanoparticle In Rapidly Soluble Vaginal Film: Promising Formulation for Pre-Exposure Prophylaxis Of HIV
Favorite
4:15 PM – 5:15 PM
(5-226) Evaluating the Evidence of Dose-Dependent Effects of Famotidine in the Treatment of Gastroesophageal Reflux in Infants
Favorite
4:15 PM – 5:15 PM
(5-227) Outcomes Associated with Inpatient Dapagliflozin Initiation in Patients with Heart Failure
Favorite
4:15 PM – 5:15 PM
(5-228) Optimizing Ophthalmic Medication Formularies: A Comprehensive Evaluation of Therapeutic Classes
Favorite
4:15 PM – 5:15 PM
(5-229) Evaluation of Daily Multivitamin Use and Cognition in 911 World Trade Center Responders
Favorite
4:15 PM – 5:15 PM
(5-230) Effects of Acquired Drug Resistance by altered gene expression on Disease Free Survival (DFS) Rates in Trastuzumab Versus Lapatinib for HER2 Positive Breast Cancer Patients
Favorite
4:15 PM – 5:15 PM
(5-231) Student Pharmacists Comparing the Utilization of Continuous Glucose Monitors vs Blood Glucose Meters
Favorite
4:15 PM – 5:15 PM
(5-232) Developing a Drug Information Website
Favorite
4:15 PM – 5:15 PM
(5-233) Review of antibiotic dosing recommendations in obese adults across online databases and from the American College of Clinical Pharmacy (ACCP) guidelines
Favorite
4:15 PM – 5:15 PM
(5-234) Evaluation of Enoxaparin Dosing and Target anti-Xa Achievement in Neonates by Postmenstrual Age
Favorite
4:15 PM – 5:15 PM
(5-235) Review of Patient-Reported Outcomes (PRO) information in labels for New Drug Approvals (NDAs) for oncology drugs approved by the Food and Drug Administration (FDA): 2011-2023
Favorite
4:15 PM – 5:15 PM
(5-236) Comparison of fentanyl and hydromorphone in an obese patient population
Favorite
4:15 PM – 5:15 PM
(5-237) Enhancing Renal Dosing Through Pharmacist Intervention: A Retrospective Study at Bellevue Hospital
Favorite
4:15 PM – 5:15 PM
(5-238) Identifying Prevalence and the Role of Social Media in Eating Disorder Behaviors of St. John’s University Students
Favorite
4:15 PM – 5:15 PM
(5-239) Cytochrome P450 2C19 Polymorphism in Patients with Gastroesophageal Reflux Disease Taking Proton Pump Inhibitors: a Meta-Analysis.
Favorite
4:15 PM – 5:15 PM
(5-240) Evaluation of Guideline-Directed Medical Therapy and Blood Pressure Control in Patients Enrolled in a Pharmacist-Led Heart Failure Remote Patient Monitoring Program
Favorite
4:15 PM – 5:15 PM
(5-241) BUG OFF Instagram for Infectious Diseases NAPLEX Prep
Favorite
4:15 PM – 5:15 PM
(5-242) Economic Evaluation of Antibody Drug Conjugates (ADC) Compared to Standard of Care and Other Emerging Therapies: A Systematic Literature Review
Favorite
4:15 PM – 5:15 PM
(5-243) Students' perception on the co-curricular activities in the College of Pharmacy at St. John’s University
Favorite
4:15 PM – 5:15 PM
(5-245) Food Insecurity Amongst College Students at St. John's University Queens Campus
Favorite
4:15 PM – 5:15 PM
(5-246) Faculty Engagement, Perspectives and Barriers to Mentoring Student Research Projects
Favorite
4:15 PM – 5:15 PM
(5-247) Medication Use Evaluation of Ciprofloxacin at Nassau University Medical Center
Favorite
4:15 PM – 5:15 PM
(5-248) Intranasal vs. Intravenous Ketamine: A Case Series Towards PK/PD Optimization in Clinical Psychiatry
Favorite
4:15 PM – 5:15 PM
(5-249) Optimizing Therapeutic Drug Monitoring and Dosing Practices of Vancomycin in Adults: A Systematic Review of Knowledge, Perspectives, and Practices Among Current and Future Pharmacists
Favorite
4:15 PM – 5:15 PM
(5-250) Retrospective Review of Dexmedetomidine Sublingual and Ketamine Injectables in the Emergency Department for Management of Acute Agitation
Favorite
4:15 PM – 5:15 PM
(5-251) Revolutionizing Healthcare: Empowering Low-income communities through Streamlined Drug Utilization and Prior Authorization Processes for SGLT2 inhibitors.
Favorite
4:15 PM – 5:15 PM
(5-252) Comparison of Intranasal Corticosteroids to Intranasal Corticosteroids Plus Intranasal Antihistamines on 9/11 Responders with Chronic Rhinitis
Favorite
4:15 PM – 5:15 PM
(5-253) Oral Contraceptive (Ethinyl Estradiol and Norethindrone Acetate)-Induced Hepatic Adenomas: A Case Report
Favorite
4:15 PM – 5:15 PM
(5-254) Effects of Fluid Balance and/or Diuretic Use on Clinical Outcomes in Children with Bronchiolitis: A Critical Review of the Literature
Favorite
4:15 PM – 5:15 PM
(5-256) Health Disparities in Management of Asymptomatic Bacteriuria (ASB)
Favorite
4:15 PM – 5:15 PM
(5-257) Health Disparities in Management of Symptomatic Urinary Tract Infections
Favorite
4:15 PM – 5:15 PM
(5-258) Impact of ChatGPT Use on Achievement of Curriculum Outcomes and Entrustable Professional Activities (COEPA) during Advanced Pharmacy Practice Experiences (APPEs)
Favorite
4:15 PM – 5:15 PM
(5-259) Teaching Clinical Documentation to Student Pharmacists: A Comparison of SOAP Notes and Consult Notes
Favorite
4:15 PM – 5:15 PM
(5-260) Role of Fidaxomicin in Pediatric Clostridioides Difficile Infection Management
Favorite
4:15 PM – 5:15 PM
(5-261) Content Analysis of Food and Drug Administration (FDA) Warning Letters Issued March 2020-September 2023 for Products with Fraudulent COVID-19 Prevention and Treatment Claims
Favorite
4:15 PM – 5:15 PM
(5-262) Knowledge, Attitudes, and Awareness of Climate Change and Health Among Pharmacy Students
Favorite
4:15 PM – 5:15 PM
(5-263) Identifying Barriers and Improving Fingerstick Monitoring for Glycemic Control at an Academic Medical Center
Favorite
4:15 PM – 5:15 PM
(5-264) Assessing the Appropriateness of Gentamicin Use for Surgical Prophylaxis
Favorite
4:15 PM – 5:15 PM
(5-265) Evaluating Efficacy of Artificial Intelligence and Machine-Learning Derived Treatments: Systematic Review
Favorite
4:15 PM – 5:15 PM
(5-267) Clinical Interventions Made by Doctor of Pharmacy Candidates in a Geriatric-Focused Inpatient Care Advanced Pharmacy Practice Experience
Favorite
4:15 PM – 5:15 PM
(5-268) Advancing Health Equity in Hypertension Management for Hispanic Americans
Favorite
4:15 PM – 5:15 PM
(5-269) Impact of Antipsychotics on Continuous Infusion Sedative Requirements in Mechanically Ventilated Critical Care Patients
Favorite
4:15 PM – 5:15 PM
(5-270) Advancing Healthcare Equity in Diabetes Management for Hispanic Americans
Favorite
4:15 PM – 5:15 PM
(5-271) Unveiling the Complex Landscape of Antipsychotic Drug Discontinuation: A Scoping Review of Clinical and Socioeconomic Impacts
Favorite
4:15 PM – 5:15 PM
(5-272) Longitudinal Efficacy Analysis of New York State’s (NYS) Office of Alcoholism and Substance Abuse Services (OASAS) Program
Favorite
4:15 PM – 5:15 PM
(5-273) Rising Cases of Drug–Induced Pulmonary Fibrosis
Favorite
4:15 PM – 5:15 PM
(5-274) Doxorubicin Stability when Prepared in Closed System Transfer Device Syringes
Favorite
4:15 PM – 5:15 PM
(5-275) Coming Together in the Community: A Pharmacy-Led Interprofessional Outreach Initiative
Favorite
4:15 PM – 5:15 PM
(5-276) A Rare Case of Neurogenic Pulmonary Edema Post Epileptic Seizure
Favorite
4:15 PM – 5:15 PM
(5-277) The Pathophysiological Aspects of Respiratory Syncytial Virus Infection
Favorite
4:15 PM – 5:15 PM
(5-278) Therapeutic Use of Compounded Topical Cidofovir in Acyclovir-Resistant Genital Herpes Simplex Virus Type 2 (HSV-2) Infection
Favorite
4:15 PM – 5:15 PM
(5-279) Enhancing Electronic Health Record (HER) Reliability: A Replicable Approach for Healthcare Downtime Management
Favorite
4:15 PM – 5:15 PM
(5-280) Side Effects of Miscellaneous Antibacterial Drugs
Favorite
4:15 PM – 5:15 PM
(5-281) The Impact of Biofire® Filmarray® on Antibiotic Selection for Gram-Positive Blood Cultures of Patients With Bacteremia in a Community Teaching Hospital.
Favorite
4:15 PM – 5:15 PM
(5-282) A Systematic Review of Effectiveness of Oral Semaglutide in Type 2 Diabetes
Favorite
4:15 PM – 5:15 PM
(5-283) Clinical Utility of Methicillin-resistant Staphylococcus aureus (MRSA) Surveillance Cultures in Non-pulmonary Infections at a Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-284) Efficacy of crisaborole ointment 2% versus topical corticosteroids in treatment of atopic dermatitis
Favorite
4:15 PM – 5:15 PM
(5-285) 3-dimensional printing technologies employed in Fixed-Dose Combination (FDC) drugs
Favorite
4:15 PM – 5:15 PM
(5-286) The Integration of AI in Pharmacovigilance Case Processing: Enhancements, Challenges, and Future Prospects
Favorite
4:15 PM – 5:15 PM
(5-287) Clinical utility of Methicillin-Resistant Staphylococcus Aureus (MRSA) nasal screening in Skin and Soft Tissue Infection (SSTI) at a Community Teaching Hospital
Favorite
4:15 PM – 5:15 PM
(5-288) Systemic Review of the Toxicology of Triple Antiretroviral Combination Agents
Favorite
4:15 PM – 5:15 PM
(5-289) Evaluating Cardiologist's Knowledge of Pharmacogenomics
Favorite
4:15 PM – 5:15 PM
(5-290) The Statin Dilemma: The Benefits Outweigh the Risks of Treating Hypercholesterolemia
Favorite
4:15 PM – 5:15 PM
(5-291) Neuroregenerative and Neuroplastic Effects of Thymoquinone on Alzheimer's Disease
Favorite
4:15 PM – 5:15 PM
(5-293) Combination of the Latest Generation Antimicrobials Aimed to Improve Patient Outcome: A Novel Regimen to Combat the Pan-Resistance Klebsiella pneumoniae
Favorite
4:15 PM – 5:15 PM
(5-294) Breaking Resistance Barriers to Improve the Care of Patients: Aztreonam as a Last Line of Defense to Combat Pseudomonas aeruginosa Mutators
Favorite
4:15 PM – 5:15 PM
(5-295) Investigating Bacterial Co-Infection Among Hospitalized COVID-19 Patients
Favorite
4:15 PM – 5:15 PM
(5-296) Retrospective Review of Antibiotic Prescribing Patterns in Children at Hospital Discharge
Favorite
4:15 PM – 5:15 PM
(5-297) Clinical Pharmacology Research Application - Pharmacy Students and Residents Utilize Research Electronic Data Capture (REDCap) for Data Entry during an NIH-funded Study
Favorite
4:15 PM – 5:15 PM
(5-298) Retrospective Evaluation of Metronidazole Use During Months of Increased Order Volume
Favorite
4:15 PM – 5:15 PM
(5-299) Influence of HUMC1/ΔmtgA knockout on Acinetobacter baumannii on Beta-Lactam Pharmacodynamics
Favorite
4:15 PM – 5:15 PM
(5-300) Implications and Management of Polypharmacy in Older Adults and Special Populations: A Systematic Review
Favorite
4:15 PM – 5:15 PM
(5-301) Evaluation of a Pharmacist-Led Chronic Care Management (CCM) Program
Favorite
4:15 PM – 5:15 PM
(5-302) Intravenous Olanzapine for the Treatment of Abdominal Pain in the Emergency Department
Favorite
4:15 PM – 5:15 PM
(5-303) Enhancing Reproductive Health Management in Sickle-Cell Disease Through Interprofessional Grand Rounds Education
Favorite
4:15 PM – 5:15 PM
(5-304) Pharmacokinetics and Safety of Cabenuva in Renal Impairment: An Open Label Study
Favorite
4:15 PM – 5:15 PM
(5-305) Evaluating the Quality of Penicillin Allergy Documentation into an Electronic Health Record System and Its Impact on Antibiotic Selection
Favorite
4:15 PM – 5:15 PM
(5-306) Predictors of Healthcare Utilization Within 30 Days of Hospital Discharge in a Primary Care Patient Population
Favorite
4:15 PM – 5:15 PM
(5-307) Readmission Rates in Patients with Heart Failure with Reduced Ejection Fraction on Guideline-Directed Medical Therapy at Hospital Discharge
Favorite
4:15 PM – 5:15 PM
(5-308) Unmasking Long COVID: Impact of Social Determinants of Health
Favorite
4:15 PM – 5:15 PM
(5-309) Aztreonam-Induced Phenotypic Changes in Pseudomonas aeruginosa (PAO1): Implications of Persistence for Antimicrobial Treatment Strategies in Recalcitrant Infections
Favorite
4:15 PM – 5:15 PM
(5-310) Evaluation of Hyperglycemic Events in Critically Ill Patients Requiring Insulin
Favorite
4:15 PM – 5:15 PM
(5-311) Bictegravir in the Elderly Living with HIV (BICEP): Impact of Polypharmacy and Multimorbidity
Favorite
4:15 PM – 5:15 PM
(5-312) Utilizing Professional Continuous Glucose Monitors in Clinical Decision Making to Improve Glycemic Control
Favorite
4:15 PM – 5:15 PM
(5-313) Evaluation of Emergency Room Care for Vaso-Occlusive Crisis for Individuals with Sickle Cell Disease
Favorite
4:15 PM – 5:15 PM
(5-314) Managing Glaucoma: Evaluating the therapeutic role of Latanoprost and associated Conjunctival Hyperemia risk using FDA Adverse Event Reporting System
Favorite
